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The glucuronide transport membrane protein (GusB) encoded by the gusB gene is 
essential for the survival of Escherichia Coli (E. coli) residing in the gut of vertebrate 
species. This gene, along with four others located on the GUS operon, allows E. coli to 
scavenge carbon from detoxification products produced by the host. These products are 
known as glucuronides, they are composed of two parts, one is a glycone (glucuronic 
acid), and the other is an aglycone (various molecules). GusB has shown varying affinity 
for the substrates that is transports therefore recognising the glycone part very specifically 
and the agylcone part indiscriminately. However, the binding mechanism used by this 
protein this is still unknown. 
Amino acid residues within GusB must be structurally relevant for molecular recognition 
of glucuronide molecules; however information relating this is not yet available. 
Therefore, identifying key residues within the molecular recognition site of GusB became 
the focus of this research project.  
Using E. coli as a model organism, site-directed mutagenesis and cloning techniques 
employed in the laboratory were used to create six residual amino acid changes within the 
Glucuronide Transporter Protein. These occurred at various positions within the predicted 
cytoplasmic region of GusB. By substituting amino acids to others with different charges 
and polarity, it was expected that protein folding mechanisms and the molecular 
recognition site would be disrupted. Glucuronide transport activity was predicted to 
change as a result. 
Successful cloning to create mutant GusB proteins could not be achieved however, 
sequence analysis of a previous plasmid pE349 encoding a mutant GusB found an 
unexpected amino acid mutation at position 218 of the glucuronide membrane transporter. 
Chromogenic GUS assays showed the change from Asparginine (uncharged) to Lysine 
(positively charged) caused a reduction in the transport rate of glucuronides. This led to 
questions as to whether this amino acid change was indeed part of the molecular 
recognition site. All steps undertaken for mutagenesis and cloning techniques have been 
detailed and proposals for further research are highlighted. It is hoped that by identifying 
key amino acid residues, this protein could be manipulated in the future to recognise very 
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1. Introduction  
 
1.1 An overview of the project 
 
The bacterium Escherichia coli is known to inhabit the gut of most endothermic vertebrate 
species (Denamur et al., 2010). For these organisms to thrive in such environments, they 
must have a distinct mechanism in place to acquire all the relevant nutrients related to their 
survival.   
Within host species including humans and other mammals, detoxification products known 
as glucuronides provide a valuable carbon source for the bacteria (Csala et al., 2004; Ishii 
and Sadowski 2008; Gloux et al., 2010). Everyday exposure to harmful substances is a 
constant threat to animal species and therefore a reliable defense mechanism must be in 
place. Glucuronides are formed of two components, the first is the aglycone component; 
these are substances considered toxic to the organism. These include endogenous 
metabolic waste, xenobotics, steroids, vitamins, hormones and pharmaceutical drugs 
(Argikar, 2012). For these to be excreted, they must first become covalently bound to a 
glucuronic acid also known as a glycone, in turn increasing the polarity of the molecule 
and the likelihood of elimination (Fujiwara et al., 2018, King et al., 2000, Tephley et al., 
1990; Compernolle 1978). However, commensal or symbiotic bacteria inhabiting the 
gastrointestinal tract are responsible for the alternate fate of these glucuronide molecules.  
The E. coli bacterium harnesses the ability to transport glucuronides across the cell 
membrane where they then cleave the molecule in two. The aglycone component is of no 
use to E. coli, this part will be transported back across the bacterial membrane where it is 
subsequently excreted or re-absorbed by the host in a process known as enterohepatic 
circulation (Gibson and Skett 2002; Guillemette 2003; Xia et al., 2012). The glycone is 
used as a source of energy, and the symbiotic relationship between the host and bacteria is 
established.  
This process is essential to E. coli however; it would be impossible without a particular set 
of proteins encoded by the genes of the GUS operon (Hughes et al., 1992, Jain et al., 
2006). Operons are described as clusters of genes that are transcribed in a single mRNA or 
with a single promoter (Alberts et al., 2002; Osbourn and Fields 2009; Alberts et al., 2014). 
It may seem obvious then that genes transcribing proteins with similar properties or whose 




that particular system can then work more effectively as a result priving beneficial to the 
organism (Dandekar et al., 1998; Ralston 2008).   
A novel example of this comes from the more widely known, Lac Operon. When Glucose 
is not readily available, E. coli is able to metabolise lactose as an alternate source of energy 
(Griffiths et al., 1999; Becker et al 2013). However, in order to do this they require 
proteins LacY, LacZ, and LacA. This operon will only be expressed under two conditions; 
firstly lactose must be present, this is detected by a lac repressor protein found on the 
operon. Secondly, glucose cannot be present which is detected by another repressor, the 
catabolic activator protein (Ullmann 2009). If these conditions are met, the inducer 
allactose will bind to the lac repressor and remove it from the operator region. This in turn 
allows DNA polymerase to bind to the promoter region and transcription of the desired 
genes can ensue. CAP is responsible for binding near to the promoter and encourages the 
binding of DNA polymerase therefore in turn increasing the rate of transcription (Griffiths 
et al., 1999; Alcantara 2015). Having all of these genes controlled under the same operon, 
it means that the enzymes and other proteins needed for lactose metabolism are only 
produced when they are really needed. This ensures that unnecessary energy is not 
expended by the bacteria (Dean et al., 2008). 
Although less widely studied, the Gus Operon is thought to work in a similar way. Within 
the GUS operon specifically, four genes are present. gusR encodes a repressor protein 
ultimately controlling the transcription of the other functional genes on the operon . Once 
the desired substrate, in this case a glucuronidated ligand, is present the repressor protein 
encoded by gusR will temporarily become disassociated from the regulatory region 
(Hughes et al., 1992; Little et al., 2017). This allows the operator-promoter region to 
become unobstructed, RNA polymerase can bind and translation of gusA, B and C into 




















Figure 1-1 Schematic of the GUS operon in Enterobacteriaceae. In the absence of a 
glucuronide ligand (R-GlcA; yellow), GusR (green) is expected to repress (red) the 
downstream transcription of the GUS operon proteins GusA, GusB, and GusC (grey) by 
binding to a specific DNA operator site. In the presence of a glucuronide ligand (e.g., p-
nitrophenyl glucuronide), GusR disassociates from the operator to allow GUS operon 
expression. As shown here, only the Enterobacteriaceae, including several opportunistic 
bacterial pathogens, contain a GUS operon and GusR (Little et al., 2017). 
 
The gusA gene encodes β-D-glucuronidase, this hydrolase is able to cleave a wide variety 
of glucuronides into its two components, the glycone and aglycone (Gloux et al., 2010). 
The gusB gene encodes a proton-linked glucuronide transporter in the cell membrane 
(Liang et al., 2005). As for gusC, the detailed mechanism of its function remains obscure; 
however one theory has suggested that it encodes an outer membrane protein aiding GusB 
with transport (Liang et al., 2005).   
Membrane transport systems are diverse, they can act for acquisition of nutrients, excretion 
of waste or toxic materials, ATP production, nerve signal relay, maintenance of membrane 
potential, pH regulation, hormone responses, oxidation and reduction of substances 
(Ludewig and Frommer 2002; Blatt 2004; Otsuka et al., 2005; Claycomb and Tran 2011; 
Garguad et al., 2011; Watson 2015).  The intricate and coordinated way operons can be 
turned on and off to allow for minimum energy expenditure shows they evolved in a 
sophisticated manner (Lodish et al., 2002). The proteins found on these operons prove to 
have sophisticated and intriguing qualities, the broad specificity of GusB, the glucuronide 
transporter proving to be one of these.  
 
In 1961, Stoebar pioneered a study in which he described the GusB protein to work via 
active transport. GusB simultaneously transports the selectively bound molecule along 
with a driving substrate in the same direction across the membrane as seen in Figure 1-2. 




example of symport transport is seen in which glucuronide uphill transport is coupled with 
the co-transport of an H
+
 ion (Kaback and Wu 1997). 
 
 
Figure 1-2 Types of transport proteins: Uniporters are the most simple example of 
transport proteins translocating a singular molecule from one side of the membrane to the 
other; symporters translocate two substances from one side to the other simultaneously, 
this is using an ion of some sort (for GusB this is a proton) and antiporters transporta 
substance one way and a second substance in the opposite direction (Alberts et al., 2002) 
 
Stoebar also presented findings showing that GusB also had differing affinities for some 
glucuronide molecules as opposed to others (Stoebar, 1961                                                                                                                                              
, Liang et al., 2005). Due to huge variations in aglycone components, questions arise of 
how this transporter can recognise glucuronides with such diverse properties. Not only this, 
but why the transport of some substrates is prioritised over others. It would seem logical to 
assume that the answer lies within the molecular recognition site of the transporter, after all 
this is where substrates bind and initiate the transport mechanism (Ariga et al., 2007). 
Structural knowledge is unavailable for the GusB protein although sequence alignments 
and hydropathy plots created in previous studies by Liang (1987) showed structural 
similarity in hydrophobic and hydrophilic regions to two other transporter proteins MelB, 
the Melibiose Carrier protein and LacS, the lactose symport protein (Gunnewijk et al., 
1999; Amin et al., 2014). It was suggested then, that this protein might too belong within 
the Major Facilitator Superfamily (Yan, 2015). Liang (1992) created a model, which 
depicted the predicted structure of GusB based on the assumption that, like the MFS 
family, the protein comprised on the 12 TM helices (Figure 1-2) (Yan, 2013). Somewhere 
amongst these helices, presumably within the outside loop, must lie the substrate binding 
site which when triggered by a complementary substance will undergo a conformational 






Figure 1-3 Predicted structure of GusB membrane transporter. GusB is show to be 
within the cell membrane with loops of amino acid residues exposed to the inide and 
outside of the cell. 12 transmembrane helices can be seen, conforming to the assumption it 
is part of the MFS. Pink shaded amino acids show positively charged amino acids on the 
periplasmic side of the membrane and yellow show negatively charged amino acids 
(adapted from Liang 1992). 
 
It was not until a study by Ishii (2010) was published that any relevant structural 
information came to light. In the study, Ishii found an elution peak corresponding to a 
pentameric structure in a number of different elution profiles using size-exclusion High-
performance liquid chromatography. He later continued his work and was able to provide 
two-dimensional electron crystallography images (See figure 1-4). Though this is 
developmental in regard to structural findings there is still a need for further work to 
identify the location or structural evidence regarding the molecular recognition site and 






Figure 1-4 Electron micrographic image of 2D crystalline array of GusB. Scale bar = 
50 nm. b Computed diffraction pattern of the 2D crystalline array of GusB indicated with a 
box in (a). The a*- and b*- axis of the hexagonal lattice are indicated. The dotted circle 
line corresponds to a spacing of 2.8 nm. Diffraction bar is 0.1 nm-1 . c Fourier-filtered 
image of 2D crystalline array showing the diffraction pattern in (b). All diffraction spots 
were masked off with Gaussian-shaped circular masks and were inverse Fourier 
transformed. a = b = 13.75 nm, and c = 120. Scale bar = 50 and 10 nm for the enlarged 
inset (Ishii et al., 2013) 
 
With the information available taken into consideration, deciphering key structural amino 
acids residues within the molecular recognition site of GusB became the focus of this 
project. Mutagenesis allows DNA within an organism to be purposely changed, this allow 
genes to be mutated therefore leading to a disruption in the final protein structure 
(Theodorakis, 2008) 
Site directed mutagenesis (SDM), one of the most common procedures, can create planned 
changes in DNA and subsequently in the amino acid sequence allowing specific amino 
acid to be substituted to another with varying properties such as charge and polarity 
(Hutchinson et al., 1978; Edelheit, 2009). The ability to deliberately make these changes 
can help to identify if amino acids are relevant to the molecular recognition site of GusB. 
Protein and enzymatic activity measurements of normal and mutated proteins can then be 
monitored and notable changes can be observed using in vivo organisms, such as E. coli 
(Storici et al., 2001).  
In total, six site-directed mutations were chosen in which specific amino acids were 
changed to another with differing properties. It is thought that this may cause changes to 
the transport and function of the protein in comparison to the glucuronide transporter 
produced by the wild type gusB on the pMJB33 plasmid (Bruce and Liang 2014). By 




pTTQ18 expression vector, amplified using PCR and then cloned into competent E. coli 
cells (Stark, 1987). pTTQ18 was used as it has a strong tac promoter, in addition to this is 
does not have a naturally occurring gusB gene within its sequence. 
Should the cloning process be successful, it is possible that this mutation will disrupt the 
structural integrity of the protein. If the residue proves to be important to either molecular 
recognition this may cause changes in transport activity indicating a disruption in the 
binding site and deeming the original amino acid structurally relevant.   
A greater understanding of singular genes and proteins in addition to the wider systems 
they support can allow us to manipulate certain parts in way which may benefit society in 
the future (Chica, 2015). Protein engineering can be particularly advantageous in the 
creation of reporter genes, bio-concentrators and biosensors (Van der Meer and Belkin 
2010, Gallagher, 2012). However, with structural and functional relationships still not 
understood these applications for GusB are still a distant prospect. By looking at this 
protein as a basic structural level, it may uncover the relevance of singular amino acids and 
internal protein interactions in turn revealing more about the molecular recognition and 
substrate binding site of GusB glucuronide membrane transporter. 
 
Due to the predicted structure of GusB alignments were conducted with MFS protein  
XylE (See Appendix 8). Although sequence homology was low, a paper published by 
Madej et al 2014 recognised mutations at position 27 created a complete loss of 
Xylose/H+ symport therefore the first mutation seen in Table 1-1 was chosen. In addition 
to this, current literature outlines the effect that amino acids substituted to another with 
different charges and polarity can have dramatic effects on protein function and more 
specifically transport (Zhang et al 2003; Schaefer and Rost, 2012). It is important to 
recognise that low sequence homology across the MFS is generally low however, 
structural similarity is common (Vardyet al., 2004; Zhang et al., 2015). 
The other mutations chosen in the inner and outer loops were somewhat random, with 
substitutions being made based on the knowledge that interactions between charges and 
polarity are important for site structure (Madej and Kaback 2013; Biggin et al., 2016). It 
would now seem obvious that mutations should have been chosen based on more protein 
alignments. In addition to this, the focus should have been on residues known to be related 
to molecular recognition. Or from alignment, amino acid matches with similar charge and 
polarity with proteins such as MelB, LacS or XylE.  This was recognised after on-going 





The substitution mutations incorporated within the gusB gene can be seen in Table 1-1. All 
plasmid maps can be found in Figure 2-1. 
 
Table 1-1 The six site-directed amino acid mutations of the gusB gene conducted in 
this study: the name of the mutation is composed of the transmembrane (TM) helices of 
the substitution mutation as well as the place the amino acid would be found within the 
gene sequence. 
Name of Mutation  Position of mutation 
on gene  
Original Amino Acid 
Residue  




TM1G27D  Glycine   
(neutral)  
Aspartic Acid  
(Negatively charged)  
pAB-L119C  TM4L119C  Leucine   
(Hydrophobic)  
Cysteine  
(Neutral)   
pAB-H183E  TM6H183E  Histidine   
(Positively charged)  
Glutamic Acid 
(Negatively Charged)  
pAB-N273D  TM8N273D  Asparagine   
(Polar)  
Aspartic Acid  
(Negatively Charged)  
pAB-E362N  TM10E362N  Glutamic Acid 
(Negatively charged)  
Asparagine  
(Polar)  
pAB-R406E  TM12R406E  Arginine   
(Positively charged)  
Glutamic Acid 

















1.2 Aims and Objectives  
  
Aim:   
The main aim of this project is to identify key amino acids within the molecular 
recognition site of the E. coli transporter protein GusB.  
 
Objectives:  
The first objective of this project is to design oligonucleotide primers for site specific 
mutations at the correct position on the gusB gene; this should be thought of logically and 
should be designed with consideration to conduct successful PCR reaction. Therefore, 
annealing temperature, GC content and length should be taken into consideration.  
 
Next, using PCR based site-directed mutagenesis; the six chosen mutations as seen in 
Table 1-1 should be individually amplified.  
 
Using corresponding molecular cloning techniques, the mutated gusB gene will then be 
cloned into the pTTQ18 vector and finally introduced into competent E. coli strains.  
Transport based tests (GUS Assay) using chromogenic pPNG will be performed to 
determine whether amino acid mutations cause changes to transport and possibly 
disruption to the molecular recognition site. Binding affinity of specific glucuronides will 
also be assessed.  
 
The clones will be sequenced to see if the desired mutation has been incorporated into the 













2. Materials and Methods 
 
Throughout this project, procedures relating to cloning and site directed mutagenesis were 
undertaken in the laboratory spanning over approximately a one-year basis. Lab work was 
extended from a 6-month to a 12-month period due to a lack of results from cloning 
procedures and the troubleshooting which followed.  
All lab work was undertaken at Bournemouth University under the direction and help of Dr 
Wei Jun Liang who supervised the project.  
It was essential that before any laboratory work could begin both induction and equipment 
training was completed. In addition to this several forms including risk assessment and 
COSHH were completed. Due to the use of E. coli rather than mammalian or human 
tissues an ethical checklist was not necessary. All procedures are outlined in the following 
pages listed in the order they were undertaken, please note these are approximate and some 
may have been performed on multiple occasions.  
 
A list of plasmid maps for the clones in this study as well as the E. Coli strains can be 
found on the following page and referred back to as required when addressing procedures 



















Table 2-1 Bacterial Strain Information: The bacterial strains used to make competent 
cells; E.coli 5-alpha and 10-beta strains were ordered from New England Biolabs and were 




Genotype Additional Strain 
Information 
Where from 
& CatLog no 
MC1061  F– araD139 Δ(ara-leu)7696 
galE15 galK16 Δ(lac)X74 
rpsL (StrR) hsdR2 (rK– 
mK+) mcrA mcrB1 













 fhuA2 Δ(argF-lacZ)U169 
phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 
relA1 endA1 thi-1 hsdR17 
- Derivative of DH5α. 
- From K12 E. coli strain 
(Mandel 1970) 
- Transformation 
Efficiency: 1 - 5 x 108 
cfu/μg pUC19 DNA 
- T1 phage resistant 
- endonuclease I (endA1) 










Δ(ara-leu) 7697 araD139  
fhuA ΔlacX74 galK16 
galE15 e14-  
ϕ80dlacZΔM15  recA1 
relA1 endA1 nupG  rpsL 
(StrR) rph spoT1 Δ(mrr-
hsdRMS-mcrBC) 
- Derivative of MC1061 
- From K12 E. coli strain 
(Mandel 1970) 
- Transformation 
efficiency: 1–3 x 109 
cfu/µg pUC19 DNA 
-T1 phage resistant  
- endonuclease I (endA1) 














































































































































































































































































Figure 2-1 Plasmid Maps of the template plasmid used for PCR amplification and 
plasmid maps for each plasmid containing site directed mutations created specifically 
for this project. 1.Wildtype pMJB33 and the plasmids created in this research project 
containing site directed mutations in the gusB gene: 2. pAB-G27D, 3. pAB-L119C, 4. 
pAB-H183E, 5. pAB-N273D, 6. pAB-E362N, 7. pAB-R406E. The maps show all 
restriction sites as well as the tac promoter sequence, origin of replication, antibiotic-
resistant marker (Bla) and laclQ. 
 
2.1  Preparation of LB Media and LB Agar for culturing bacteria cells.  
 
LB media and Agar plates were needed throughout. They act as a nutrient base which 
enables bacteria cultures (E. coli in this study) to grow, this may be either in a liquid 
culture or agar plates on which chosen samples are streaked.  
The following constituents were added into a 1 litre (L) DURAN bottle:  
600 ml of Distilled water  
10 g Tryptone (amino acid mix)  
5 g NaCl  
10 g Yeast Extract  
Once the correct solution had been made up, the appropriate amount of distilled water was 
added to make the final volume 1 L, the glass container was placed into the autoclave 
making sure that this was put on the ‘liquid media’ setting. Another separate 1 L solution 
of LB media was made intended for agar plates therefore 15 g Agar was added before 
autoclaving the solution for around 20 minutes, a metal stirring rod was added and put onto 
a metal plate in order to mix the solution prior to autoclaving. For experiments that 
required antibiotic-containing media or plates (crucial for this project as clones with 
contain anti-biotic resistance gene), ampicillin was added to the solution AFTER the 
sterilisation using the autoclave due to the sensitivity at high temperature. In this case 
ampicillin was added at a concentration of 100g/ml.  
For plates:  
Firstly, it is essential to keep any bottle containing LB media sealed not in use to avoid 
contamination. A Bunsen burner was lit and placed on the blue flame- once the bottle was 
opened the rim and the lid of the bottle were heated for sterilisation purposed (Sanders 
2012). LB media was poured onto the plate, it was essential not to touch the lid of the 
bottle nor plate to avoid contamination.   
The plates were left to cool and set, they were then labelled appropriately with the date and 




included in the name and marks were left on the side of the plate to make this clear. They 
were kept in refrigerator until needed at other points during the project.  When 
microorganisms need to be  grown and harvested, they can be taken from pre-prepared E. 
coli samples and inoculated onto plates of liquid media. This can then be heated to promote 
bacteria growth.  
2.2 Plasmid DNA extraction:   
 
Plasmid DNA extraction (using Quicklyse Mini-prep kit from Qiagen) allows the isolation 
of plasmid DNA from bacteria strains using the alkaline lysis treatment (Ehrt and 
Schnappinger, 2003). In this project pTTQ18 was used, this plasmid vector has been 
designed to have high levels of regulated gene expression levels in addition to a strong 
promoter (Stark 1987; Surade et al., 2006).  
 
 
Figure 2-2 The pTTQ18 plasmid map this map shows the the lac promoter, lacI and lacZ 
gene, the ampicillin resistance gene, and the origin of replication. All restriction sites are 
also shown including EcoRI and KpnI which were the restriction enzymes used for this 






1ml of bacterial culture was pipetted into separate 1.5 ml microcentrifuge tubes. These 
were clearly labelled to avoid any mix up throughout the process. Each sample was then 
placed into the centrifuge at 13,000rpm for 3 minutes to precipitate the bacteria. The liquid 
was poured away; any remanence of liquid in the tube was discarded. 250 µl of Buffer P1 
was then added to each tube containing the DNA sample; the cells were re-suspended 
using the vortex mixer. Once mixed adequately, all samples were left to stand for 2 
minutes, 250 µl of Buffer P2 was then added and the tubes were inverted 6 times. This was 
followed by the addition of 350 µl Buffer N3; tubes were shaken and then suspended 
upside down for 5-10 seconds.  
The samples were then centrifuged for 10 minutes at 13,000 rpm, 800 µl of the supernatant 
from each sample was transferred into separate spin columns using a pipette and 
centrifuged for a further minute. The aqueous flow through was discarded. 0.5 ml of Buffer 
PB was added into each spin column and centrifuged for 1 minute, the remaining liquid 
was discarded. Next the DNA left in the column was washed using 750 µl of PE buffer; 
this was centrifuged again for a further minute. An additional 350 µl of PE buffer was 
added and centrifuged for 1 minute. The liquid was again discarded then centrifuged once 
more to remove any residual buffer. All samples were put into the incubator (37˚C) for a 
few minutes to remove any ethanol left from the PE buffer, residual ethanol could inhibit 
subsequent enzymatic reactions. Once removed from the incubator the mini-column now 
containing just the purified DNA was placed into a new 1.5 Microcentrifuge tube where 50 
µl of Buffer EB was added and centrifuged for 1 minute to re-suspend the DNA within the 
solution. The filter was then removed, and it was made sure that the lid of the 
microcentrifuge was shut properly. All samples were then stored at -20°C for future use. 
Gel electrophoresis was then conducted to identify pTTQ18 according to size (4563 bp). 
2.3 Oligonucleotide Primer Design for the mutant gusB genes  
 
Oligonucleotide primers for specific PCR amplification were designed carefully all based 
on the intended DNA template, a wild type pMJB33 clone containing the gusB gene (See 
appendix 3)(Bruce and Liang 2014). The primers included site-specific mutations to create 
an amino acid change at chosen points within the sequence.  According to Dieffenbach et 
al., (1993) there are a number of general rules that should be taken into consideration. 
Primers should be 18-24 nucleotides in length, at this length they are adequate for 
specificity but short enough to bind to the template at the annealing temperature. The GC 




58°C as primers with a melting point lower than this result in non-specific binding (Lorenz 
2012). For flanking primers restriction sites for appropriate restriction enzymes had to be 
included with random nucleotides added at either end to allow cutting. Corresponding 
primers were made to have a T
m
 within 5˚C of each other so both primers will anneal to the 
template within the same reaction (Singh and Kumar 2001).   
Primers for this project are seen below:  
 
Table 2-2. The forward and reverse mutagenic primers from 5’-3’ as designed for this 
project. Nucleotides highlighted in red show where the substitution mutation needs to be 
made. The melting temperature (Tm) for forward and reverse primers are shown in the last 
column. Yellow and blue highlighted parts of the sequence represent nucleotides not 
included in the gusB sequence; these are added for efficient restriction digest later stages of 
cloning (Feeney et al., 2014). Green highlighted sections show the open reading frame of 
gusB.  
  
Name of primer 
(Forward and 
Reverse)  





5’- TTCGCAATGACGGCGCTCTT-3’  
  
































































 M  N  Q  Q  L  S  W  R  T  I  V  G  Y  S  L  G  D  V  A  N  
aacttcgccttcgcaatgggggcgctcttcctgttgagttactacaccgacgtcgctggc 
 N  F  A  F  A  M  G  A  L  F  L  L  S  Y  Y  T  D  V  A  G  
gtcggtgccgctgcggcgggcaccatgctgttactggtgcgggtattcgatgccttcgcc 
 V  G  A  A  A  A  G  T  M  L  L  L  V  R  V  F  D  A  F  A  
gacgtctttgccggacgagtggtggacagtgtgaatacccgctggggaaaattccgcccg 
 D  V  F  A  G  R  V  V  D  S  V  N  T  R  W  G  K  F  R  P  
tttttactcttcggtactgcgccgttaatgatcttcagcgtgctggtattctgggtgccg 
 F  L  L  F  G  T  A  P  L  M  I  F  S  V  L  V  F  W  V  P  
accgactggagccatggtagcaaagtggtgtatgcatatttgacctacatgggcctcggg 
 T  D  W  S  H  G  S  K  V  V  Y  A  Y  L  T  Y  M  G  L  G  
ctttgctacagcctggtgaatattccttatggttcacttgctaccgcgatgacccaacaa 
 L  C  Y  S  L  V  N  I  P  Y  G  S  L  A  T  A  M  T  Q  Q  
ccacaatcccgcgcccgtctgggcgcggctcgtgggattgccgcttcattgacctttgtc 
 P  Q  S  R  A  R  L  G  A  A  R  G  I  A  A  S  L  T  F  V  
tgcctggcatttctgataggaccgagcattaagaactccagcccggaagagatggtgtcg 
 C  L  A  F  L  I  G  P  S  I  K  N  S  S  P  E  E  M  V  S  
gtataccatttctggacaattgtgctggcgattgccggaatggtgctttacttcatctgc 
 V  Y  H  F  W  T  I  V  L  A  I  A  G  M  V  L  Y  F  I  C  
ttcaaatcgacgcgtgagaatgtggtacgtatcgttgcgcagccgtcattgaatatcagt 
 F  K  S  T  R  E  N  V  V  R  I  V  A  Q  P  S  L  N  I  S  
ctgcaaaccctgaaacggaatcgcccgctgtttatgttgtgcatcggtgcgctgtgtgtg 





 L  I  S  T  F  A  V  S  A  S  S  L  F  Y  V  R  Y  V  L  N  
gataccgggctgttcactgtgctggtactggtgcaaaacctggttggtactgtggcatcg 
 D  T  G  L  F  T  V  L  V  L  V  Q  N  L  V  G  T  V  A  S  
gcaccgctggtgccggggatggtcgcgaggatcggtaaaaagaataccttcctgattggc 
 A  P  L  V  P  G  M  V  A  R  I  G  K  K  N  T  F  L  I  G  
gctttgctgggaacctgcggttatctgctgttcttctgggtttccgtctggtcactgccg 
 A  L  L  G  T  C  G  Y  L  L  F  F  W  V  S  V  W  S  L  P  
gtggcgttggttgcgttggccatcgcttcaattggtcagggcgttaccatgaccgtgatg 
 V  A  L  V  A  L  A  I  A  S  I  G  Q  G  V  T  M  T  V  M  
tgggcgctggaagctgataccgtagaatacggtgaatacctgaccggcgtgcgaattgaa 
 W  A  L  E  A  D  T  V  E  Y  G  E  Y  L  T  G  V  R  I  E  
gggctcacctattcactattctcatttacccgtaaatgcggtcaggcaatcggaggttca 
 G  L  T  Y  S  L  F  S  F  T  R  K  C  G  Q  A  I  G  G  S  
attcctgcctttattttggggttaagcggatatatcgccaatcaggtgcaaacgccggaa 
 I  P  A  F  I  L  G  L  S  G  Y  I  A  N  Q  V  Q  T  P  E  
gttattatgggcatccgcacatcaattgccttagtaccttgcggatttatgctactggca 
 V  I  M  G  I  R  T  S  I  A  L  V  P  C  G  F  M  L  L  A  
ttcgttattatctggttttatccgctcacggataaaaaattcaaagaaatcgtggttgaa 
 F  V  I  I  W  F  Y  P  L  T  D  K  K  F  K  E  I  V  V  E  
attgataatcgtaaaaaagtgcagcagcaattaatcagcgatatcactaattaa 
 I  D  N  R  K  K  V  Q  Q  Q  L  I  S  D  I  T  N 
 
Figure 2-3 The GusB Nucleotide and Protein sequence. Highlighted section show where 
each set of forward and reverse primers will bind to the sequence. The highlighted amino 
acid underneath the nucleotide sequence identifies the location where the substitution 
mutation will occur. Yellow: TM1G27D Pink: TM4L119C Green: TM6H183E Grey: 
TM8N273D Turquoise: TM10E362N Red: TM12R406E. Forward primers will attach to 
the template DNA fragment at the start of the highlighted sequence for each mutant and 
copy until the stop codon on the gene. This will happen in reverse for the reverse primers 
therefore creating fragments with different molecular weights. 
 
2.4 Diluting Primers   
 
After designing the primers, the proposed sequences were ordered from Eurofins 
(www.eurofins.co.uk), these were rehydrated with TE buffer to a concentration of 100M 
and stored at –20˚C until further use. The buffer should have a pH of 8 to stop DNases 
from reacting with other substrates (Bansal 2013).  
 
2.5 DNA template and vector preparation  
 
For this project gusB was the gene of interest, therefore a DNA template containing this 
gene must be prepared prior to use in the later stages of cloning. It was also essential to 
prepare the expression vector pTTQ18 as this would be needed towards the end of the 




pMJB33 and pTTQ18 samples had been stored at -80°C to ensure no enzymatic reactions 
occurred and degradation of samples was prevented.  
E. coli cultures containing the plasmids were streaked onto agar plates using a sterile metal 
loop. All the plates contained ampicillin in order to prevent the growth of bacteria that did 
not contain the gene of interest.   
It is important to note that plasmid vectors containing the gene of interest also included an 
antibiotic resistance gene; this meant bacterial strains that had taken up the plasmid could 
still be harvested on these plates, even in the presence of ampicillin.  
NOTE:  the metal loop used to streak cells was sterilised before and after streaking to 
avoid contamination (Sanders 2012).   
The plates streaked with bacteria were placed upside down into an incubator at 37°C and 
left overnight in order avoid loss of moisture. This can also help to stop unwanted 
contaminants or condensation falling from the lids onto the agar plates (Kercher 1995).  
The following morning the plated samples were checked for signs of bacterial growth. 
Bacteria colonies were present and strains could be inoculated into liquid LB media.  
All samples were put into a shaking incubator at 250rpm at 37°C then left overnight. The 
following morning checks were made to see if cells had grown, if the mixture was cloudy 
this had been successful and plasmid DNA extraction using the QIAGEN mini-prep kit 
could go ahead (see Section 2.2).  
2.6 Concentration determination of plasmid DNA  
 
Concentration of DNA and protein was measured at A260nm/A280nm with using a 
Nanodrop2000™. The Nano-drop measures the absorbance of UV radiation by DNA to 
determine the purity of the sample. A260 values represent the concentration of nucleotides 
and A280 values represent the concentration of purified protein. Assessing the concentration 
of DNA it is possible to calculate the optimum primer dilution for PCR to be calculated. 
This increases the chances of successful PCR results. In this study pMJB33 was used as 
this plasmid already contained a functioning GUS operon.  
For primer DNA, concentrations of 50l were optimum with A260 readings of between 0.2-
0.8. The A260/A280 ratio should be between 1.8-2 in order to be within optimal purity 
range.  For any results that exceeded this, dilutions were made, and samples were 
measured again until they met optimum absorbency levels.  





2.7 dNTPs Preparation  
 
To amplify DNA, a dNTP solution containing four nucleotide bases was needed 
containing dATP (adenine), dCTP (cysteine), dGTP (guanine) and dTTP (thymine). The 
stock solution should have a final concentration of 10 mM. The stock solution can be 
stored in a freezer and aliquoted when needed in PCR reactions. The stock should be 
diluted accordingly prior to carrying out any further reactions to the optimum 
concentration of 2mM.  
 
Table 2-3. dNTP recipe for 100mM stock solution containing sodium salts: dATP 
(adenine), dCTP (cysteine), dGTP (guanine) and dTTP (thymine) are all needed for 
amplification reactions.  
Component   Amount (µl)  Concentration  
dATP  25  100 mM  
dGTP  25  100 mM  
dCTP  25  100 mM  
dTCP  25  100 mM  
Distilled H2O  150  n/a  
   
2.8 Amplification of DNA using the Polymerase Chain Reaction (PCR)   
 
The polymerase chain reaction is a technique invented by Kary Mullis (1983). The main 
objective of PCR is to copy a specific DNA sequence and then amplify this to produce 
thousands or sometimes even millions more. It is essential for the next steps in the cloning 
process and in eventually obtaining mutated GusB proteins.  Before beginning the 













Table 2-4 PCR Amplification Reaction Mix. Constituents needed for a 50 µl reaction 
solution to carry out PCR amplification: Volume and concentration for each have been 
given.  
Constituent  Amount 
needed (µl)  
Final 
Concentration   
Distilled H2O (dH20)                                                    32.5  -  
5X Green GoTaq® Flexi Reaction Buffer (Promega 
Ltd)                              
10  -  
25 mM 
MgCl2                                                                                  
2  1 mM  
1 mM dNTP                                                        1  20 µM  
10 µM Primer DNA (Forward)               1  0.2 µM  
10 µM Primer DNA  
(Reverse)                    
1  0.2 µM  
Plasmid DNA (pMJB33)                                                   2  27.1 ng 
GoTaq DNA Polymerase (Promega 
Ltd)                                 
0.5  5 u/µl  
  
Primers listed in section 2.2 required a further 1 in 10 dilution for the PCR reaction. It 
made sense to make up a bulk batch for future use therefore 10µl of each primer was 
aliquoted to the corresponding 0.5ml Microcentrifuge tube, 90 µl of distilled H2O was then 
added and mixed thoroughly with a pipette. This meant that the primer solution was readily 
available at the correct concentration of 0.2 µM.  
Twelve 0.2 ml PCR tubes were labelled according to sample name, 32.5 µl of distilled H2O 
was added to all tubes. Next 10 µl of 5X Flexi buffer was added, this increases sample 
density, which helps it to sink into gel wells during electrophoresis. 2 µl of 25 mM MgCl2 
and 1 µl of 1 mM dNTP was also added to all tubes. These components can be made into a 
master mix before allocating into separate aliquots for each PCR reaction.  
Each specifically designed primer with the desired mutation (as seen in Table 2-2) was 
added to the reaction mix. Each primer, at this stage, was added to a singular and separate 
reaction to the others therefore meaning there were 12 different PCR tubes containing 
differing primers in each. Depending on the nature of the primer, a corresponding forward 





Figure 2-4 A diagram to show the overlap extension of DNA fragments in PCR 
amplification. Two DNA fragments are amplified with primers containing an overlapping 
sequence. One fragment is amplified first a 5’ primer and the other fragment is with a 3’ 
primer. After amplification of both the DNA fragments is mixed, PCR is performed with 
primers to produce fused DNA. Primer annealing allows an overlap extension reaction, 
resulting in fusion of the two fragments containing the desired mutation. 
 
The template DNA (pMJB33) was aliquoted to all PCR tubes and the solution was gently 
mixed using a pipette. Finally, GoTaq polymerase was added and all tubes which were 
immediately placed on ice. The temperature needed for annealing in a PCR reaction 
depends on the Tm of the primers, because each primer has a different annealing 
temperature a gradient PCR programme is beneficial (Fukui and Ishii, 2001). This allows 
each sample to work at the optimum annealing  temperatures which often reduces the 




The samples were placed into the Peqstar Thermocycler PCR machine. All relevant 
conditions used for PCR amplification can be seen in Table 2-4.  Once removed all 
samples were immediately stored in the freezer until gel electrophoresis was performed. 
 
Table 2-5. Recommended PCR thermal cycling conditions when using the GoTaq© 
DNA Polymerase in PCR amplification- As recommended by Promega™ 
Step Temperature (C) Time (minutes) Number of Cycles 
Initial Denaturation 95 2 1 
Denaturation 95 1 30 
Annealing 58-62* 1 30 
Extension 72 1 30 
Final Extension 72 5 1 
Soak 4 Indefinite 1 
* This differed depending on the Tm of primers designed for this project as seen in Table 2-
2. 
2.9 Fusion of gene fragments using fusion PCR  
 
After the PCR products were ‘cleaned up’ using the QIAquick PCR Purification Kit 
(catalogue number 28104). Oligonucleotide primers were diluted 10 times in Tris EDTA 
(T10E1) buffer, because the DNA concentration within the samples from primary PCR was 
too high. For fusion PCR to be successful both mutated forward and reverse DNA primers 
must be fused together in order to produce a single double stranded fragment containing 
the desired mutation (as created using primer design).  
The PCR reaction included a temperature gradient at which the primer melting temperature 
of both forward and reverse primers were taken into consideration, a temperature that 
would allow for the binding of both primers to the template DNA. 
 











Table 2-6. Constituents needed for PCR amplification intended for fusion of gene 
fragments. This applies to the amount of each component needed to make up a 50µl 
solution volume and final concentration of each is stated below. 
Constituent  Amount 





Distilled H2O (dH20)                                                    32.5  -  
5X Green GoTaq® Flexi Reaction Buffer (Promega 
Ltd)                              
10  -  
25 mM 
MgCl2                                                                                  
2  1 mM  
1 mM dNTPs                                                        1  20 µM  
EcoRI forward flanking primer                        1  0.2 µM  
KpnI Reserve flanking 
primer                                                         
1  0.2 µM  
Forward primer (samples 1-6)                       2  30-50ng  
Reverse primer (samples 1-6)                        2  30-50ng  
GoTaq DNA Polymerase (Promega 
Ltd)                                 
0.5  5 u/µl  
  
2.10 Preparing electrophoresis buffer  
 
Tris-acetate-EDTA (TAE) is a commonly used buffer for agarose electrophoresis where 
DNA can be separated according to the size of the fragment. A concentrated stock solution 
(50x TAE) was made prior to performing Gel Electrophoresis. 
2.11 Gel Electrophoresis  
 
The purpose of gel electrophoresis is to separate DNA fragments according to their 
molecular size. A corresponding molecular weight ‘ladder’ was used as means of 
determining the size of each product on the gel. This allows identification of products 
yielded during PCR amplification, based on their expected size and molecular weight. An 




migrate through the agarose gel towards the positive electrode. If the size of the DNA 
fragment is larger it will migrate at a slower rate and vice versa (Lee et al., 2012).  
 
2.11.1 Electrophoresis gel preparation  
 
40 ml of 1X TAE (Tris-Acetate-EDTA) buffer was measured in a measuring cylinder and 
transferred to a flask. 0.6 g of agarose was weighed and added into the flask containing the 
1X TAE. This was swirled gently to mix then placed in the microwave until the agarose 
had dissolved fully. The mixture was left to cool for a few minutes then 0.4 ml of Sybr safe 
cell stain™ was added, the flask was swirled until the stain was evenly distributed 
throughout the solution.  This made the desired 1.5% agarose gel. 
 
2.11.2 Loading the samples for electrophoresis 
 
The 1 kilo base (kb) ladder (0.05 µg/µl) from New England Biolabs was loaded into the 
first well of the gel, located on the far-left hand side. 1 µl of green flexi buffer was 
allocated to a micro-centrifuge tube; 4 µl of the PCR product was then added and mixed 
thoroughly using a pipette. The dye contains both blue and yellow dyes which separate 
during electrophoresis, so the migration can be tracked. The 5 µl sample is then added into 
separate wells; the exact location of each sample is noted.. These steps were repeated for 
the separate PCR products.  
 
2.11.3 Electrophoresis  
 
The Bio-Rad power pack for Electrophoresis  was left to run for 40 minutes. Bubbles 
should appear at negatively charged electrode closest to the wells as DNA travels towards 
the positive electrode.  
 
2.11.4 Visualising the gel with a blue light box 
 
The gel was placed onto the surface of the blue light box getting rid of any air bubbles 
between the surface and the gel. The orange cover was placed onto of the trans illuminator 
box covering the gel, then turned on to produce the UV light.  All lights were turned off in 





2.12 DNA Purification using QIAquick PCR purification kit (Qiagen) 
 
After primary PCR it was advantageous to clean the solution of all other constituents such 
as the MgCl2, dNTP’s as well as non-specific amplification products. This ensures that in 
next stage of cloning desired DNA products from the first reaction will be purer increasing 
the chance of successful gene fusion. DNA purification was done using the QIAquick PCR 
purification kit (Qiagen).  
The final solution should contain pure DNA fragments from the PCR amplification 
process; this can be checked again using gel electrophoresis. 
 
2.13 Purification of PCR products using Sepharose  
 
Amplification of the DNA proved difficult. This could have been due to low concentration 
of DNA after purification of PCR products produced in the first round. It is also possible 
small fragments of the poly-linker were still present in the solution after purification using 
the QIAquick PCR Purification kit™. An alternative method using a Sepharose (separation 
pharmacia agarose) spin column was conducted as a means of troubleshooting with the 
hope that this would later result in fusion of PCR products. Sterile glass beads were used 
prior to this step to prevent the leaking of Sepharose and other products.  
The PCR solution was then passed through a beaded form of agarose and washed using the 
10mM Tris-EDTA Na2, pH 8.0 solution (T10E1).  
A 0.5 ml centrifuge tube was used which acted as the spin column, first the lid was 
removed, and a small hole was created in the bottom using a sterile safety pin. This was 
then placed into a larger 1.5 ml tube. Cutting the end from one of the sterilised pipette tips, 
a pipette was used to take up 50µl of the glass beads, being careful not to pick up too much 
of the solution the beads were deposited in the spin column.   
500-600 µl of Sepharose was added and then set to spin at 8000 rpm in the centrifuge for 2 
minutes, the flow through was discarded and then the sample was centrifuged again to 
remove any remaining solution and ensure the beads formed a compact layer.  
One sample from PCR amplification was added into the spin column and set to spin at 
8000 rpm for 2 minutes to allow the purified DNA to bind the membrane- this was 
repeated for each sample and due to the risk of contamination the beads were washed 




buffer is added to the column, centrifuged forcing  the purified DNA sample to be rinsed 
through into the column.  
2.14 Removal of the plasmid DNA template  
 
DpnI treatment aims to digest methylated template DNA (Mierzejewska et al., 2014). Any 
PCR products should not be methylated at the restriction site therefore any products such 
as the original plasmid DNA will be removed from the sample during this step. This mean 
helps to reduce the number of parental colonies during transformation resulting in higher 
transformation efficiency.  
To the remaining solution from DNA purification, 5.5 µl of cutsmart buffer was added 
followed by 1 µl of DpnI. This was incubated at 37˚C for 1 to 2 hours to ensure digestion 
of template DNA occurred.  
2.15 Preparation of gel for gel extraction  
 
Gel extraction involves manually extracted the desired DNA fragment from an agarose gel 
after electrophoresis. A larger gel and comb were needed; this allows an increased volume 
of the PCR sample to be used and ensures a high yield of the desired product is available 
for extraction.  
 All other steps from this point followed the previous electrophoresis method in section 
2.8.  
2.16 Purification of DNA fragments of the gusB gene using the gel           
extraction method  
 
By using gel extraction, it is possible to isolate DNA fragments. Once electrophoresis has 
been performed, desirable PCR products can be identified by their molecular weight using 
the 1kb ladder. This then allows intact pieces of the gel to be extracted and used in the 
steps of the cloning process. For this the QIAquick DNA Gel Extraction Kit (catalogue 
number 28704) was used. 
The gel was placed on a trans-illuminator where the band representing the DNA fragments 
were illuminated, a picture was then taken to document their position. Each band was cut 
from the gel using a scalpel; this had to be precise to prevent excess agarose being present 
in the sample. It was imperative to clean the scalpel immediately after use to avoid any 
contamination.  
Sterilised micro-centrifuge tubes were labelled accordingly with the sample name to avoid 




fragment was then placed into the corresponding tube and the size of the gel fragment 
could be determined. This process was repeated for each gel fragment. Next 3 volumes of a 
solubilising-binding buffer (buffer QG) was added to 1 volume of gel (100 mg~100 µl).  
All samples were incubated at 50˚C for 10 minutes; every 2-3 minutes the samples were 
suspended using a vortex to dissolve the gel. Once dissolved fully the mixture showed a 
yellow colour, if the solution was an orange/red, sodium acetate (pH5) was added to 
decrease the pH as a higher pH can decrease DNA yield. 1 gel volume of isopropanol was 
needed per sample, all together 878 µl is needed, this can then be allocated accordingly 
into the separate micro-centrifuge tubes containing the DNA fragments, once added they 
were mixed using a pipette. 2 ml of each sample was transferred into separate, labelled 
spins columns containing a collection tube; these were then put into a centrifuge to spin at 
13,000 rpm for 1 minute making sure it was balanced accordingly. Any flow through was 
discarded and placed back into the column, 500 µl the binding buffer (QG) was added and 
centrifuged for a further minute at 13,000 rpm. Flow through was discarded and 750 µl of 
PE wash buffer was added and left to stand for 2-5 minutes. All samples were centrifuged 
for 1 minute at 13,000 rpm, again flow through was discarded and samples centrifuged for 
a further 1 minute to remove any residual buffer. The spin column was added to a clean 
micro-centrifuge tube, 50 µl of elution buffer (EB) was added and centrifuged for 1 
minute, after they were put into the incubator for a few minutes to remove any ethanol then 
stored in freezer for future use in the cloning process.  
2.17 Preparation of DNA ends for sub cloning  
 
Both plasmid vector pTTQ18 and fused products had to be digested via restriction 
digestion. KpnI and EcoRI Enzymes corresponding to restriction sites, which do not cut 
within the gusB gene, were used.  
The following process was followed for this:  
Before starting the following components were place on ice:  
10X NEBuffer 2, 10 mg/ml BSA, KpnI, EcoRI, Plasmid expression vector DNA 
(pTTQ18), Purified DNA product and Distilled water.  
Sterilised micro-centrifuge tubes were labelled accordingly with sample name/number. 38 
μl of distilled water was added to a sterile micro-centrifuge tube using a pipette. 5 μl 10X 
NEBuffer, 10 mg/ml BSA were then added to all tubes. 5 μl of plasmid vector pTTQ18 
was added to a correctly labelled tube and 5 μl of each sample was added to correctly 




pTTQ18 plasmid and 1 μl of KpnI was added to the other tube also containing pTTQ18. 
KpnI and EcoRI were added to all purified DNA fragments, as these are able to undergo a 
double digest. These were then incubated at 37°C for 2-3 hours, all samples for double 
digest were left for 4-5 hours. .  
Electrophoresis was performed for all samples to check a cut has been made, if the process 
was successful purified DNA samples were stored in the freezer. The second restriction 
enzymes were then added to the samples and incubated for an additional 2-3 hours.  
 
2.18 DNA purification to remove enzymes used in restriction digest  
 
DNA Phenol Chloroform Extraction using phenol–chloroform–isoamyl alcohol 
(Phe/Chl/IAA, 25:24:1) (Sigma CAS number: 136112-00-0) has to be conducted, this is 
because heat it is not possible to de-active the KpnI enzyme using the heat  
Phenol-choroform-isoamyl alcohol mixture (phenol) (pH 8) was added to samples (100 
µl to samples labelled 1-6; 300 µl to samples labelled Kpn1 and EcoRI). This chemical is 
an irritant, so it is vital this process was conducting using a fume cupboard. 
Two visible layers should be seen in the bottle of phenol, however if the glass is too dark 
or this is not possible, around 300 µl of water was added into a micro-centrifuge tube 
followed by 300 µl of phenol, if the phenol sinks to the bottom and forms a separate layer 
layer this shows that the chemical is ok to use. After the phenol had been added to the 
samples they were separately vortexed in order to mix the solution. A white precipitate was 
visible (proteins) however at pH 7.8-8.3 phenol can remove RNA and protein. This meant 
the remaining solution contained DNA only. Each sample was then centrifuged at 10,000 
rpm for 10 minutes, meanwhile a new set of clean, sterilised micro-centrifuge tubes were 
labelled for each sample. The clear aqueous layer on top of the solution (this is the purified 
DNA) was transferred to a micro-centrifuge tube; the process was then repeated for each 
sample.  
This procedure must be done in an extremely precise manner to prevent contamination and 
to ensure proteins are not present in the final sample, this could affect PCR assay 
(Mirmomeni et al., 2010).  
2.19 DNA Precipitation using ethanol    
 
The steps of ethanol precipitation aim to purify and concentrate the DNA that has been 




Firstly 220 µl of Ethanol was added to samples 1-6 containing 100µl solutions, 640 µl was 
added to pTTQ18 samples labelled ‘KpnI and EcoRI’ containing 300µl solutions.  
Samples were left in the freezer at -20C overnight. 
All samples were centrifuged at 13,000 rpm for 10 minutes at 4˚C. Ethanol was poured out 
without disturbing the DNA; this was then covered with tin foil and left at room 
temperature overnight to dry the DNA precipitate. 100 µl of binding buffer (PB) was added 
to samples 1-6 and 200 µl to pTTQ18 Samples ‘KpnI and EcoRI’. These were left at room 
temperature for 20 minutes. Each sample was mixed slowly by pipetting then transferred to 
labelled spin columns.  The method for PCR purification using the QIAquick PCR 
purification kit™ was used to obtain 30 µl of each concentrated sample (Section 2.9). 
Agarose Gel Electrophoresis was then performed on an agar gel to see if the DNA was 
present (Section 2.11)  
2.20 Dephosphorylation of 5’ end of DNA  
 
In the cloning process this step, Shrimp Alkaline Phosphatase (SAP) Treatment is used to 
dephosphorylate the 5’ ends of the DNA, this will stop the plasmid DNA from re-ligating 
(Nilsen et al., 2001). It is essential that it remains linearised; uptake of the mutated DNA 
fragment by the plasmid is required in the next step which would be impossible should re-
ligation occur. This step therefore reduces background colonies in future steps.  
For each 30 µl sample 3.5 µl of 10X cutsmart buffer and 1 µl of SAP was added, these 
were put into the incubator at 37˚C for 30-60 minutes. To inactivate the SAP enzyme the 
samples were then incubated 65˚C for 5 minutes on a heat block.  
2.21 Ligation of desired DNA fragments  
 
Ligation allows the vector DNA (pTTQ18)(See Figure 2-2) to join with the PCR products 
containing the mutated gene (New England Biolabs 2017).  
Once this step was complete, the ligation reaction was set up using controls and left 
overnight at 16°C. The next morning the mixture was then heat shocked at 65°C for 10 









Table 2-7 Ligation mix containing different ratios of vector to insert DNA - shown in 
red. ‘*Control 1’ shows uncut pTTQ18 (will produce colonies if conditions are optimal for 
the reaction) as a positive control to test transformation efficiency in the next step of 
cloning ‘**Control 2’ shows cut pTTQ18 used as a negative control in the next step; this 
should produce no colonies. L1 refers to the reaction mix with a vector ratio of 1:1, L2 
refers to the reaction mix with a vector ratio of 1:2 and L3 refers to the reaction mix with a 
vector ratio of 1:3. 
  Volume (µl)  
  
 Volume (µl)  
 
Volume (µl)  
  
 Volume (µl)  
 
 Volume (µl)  
 
Components  Control 1*  Control 2**  L1 (samples 
1-6) (1:1)  
L2 (samples 
1-6) (1:2)  
L3 (samples 
1-6) (1:3)  
Vector   1  1  1   1  1  
Insert  -  -  1  2  3  
10X Ligase 
Buffer  
2  2  2  2  2  
T4 Ligase  -  1  1  1  1  
H2O  17  16  15  14  13  
  
2.22 Making Competent Cells  
 
Although some competent DH5α E. coli cells DH10β were brought from New England 
Biolabs, another strain MC1061 obtained from my supervisor Wei-Jun Liang’s previous 
work was used, this needed to be made competent before use using a calcium chloride 
procedure (see Table 2-1 for relevant information on strains).  
MC1061 is a parental NO2947 E. coli strain previously used successfully by my supervisor 
Wei-Jun Liang for inner membrane protein research due to its ability to tolerate high level 
of expression. MC1061 has a functional gusA however; the gusB is non-functional due to a 
mutation at the 100
th
 codon from Proline to Leucine. This would decrease the chances of 
background activity from E. coli strains and transport seen would likely be the results of 
MC1061 successfully taking up the pTTQ18 plasmid containing the mutated gusB. In 
addition to this it has an IPTG-inducible tac promoter, therefore this strain will used for 
transport tests should transformation be successful.  
The other strains were used due to their high transformation efficiency; this was needed 
due to such low concentrations of DNA being present after ligation meaning super 




plasmids could then be extracted using the mini-prep procedure and transformed into 
MC1061 cells for transport tests and future protein work. 
E. coli MC1061 was inoculated in LB media overnight placed in the orbital shaker at a 
temperature of 37°C in order to promote growth. The MC1061 culture was inoculated into 
fresh liquid media and  was set to shake vigorously until the cells reached A600 = 0.2-0.3 
also known as log phase. Once log phase was reached the culture was chilled on ice, 1 ml 
of cells were then transferred to micro-centrifuge tubes and put into the centrifuge for 2 
minutes at 10,000 rpm at a temperature of 4°C. The supernatant was discarded and the 
cells were re-suspended in 0.5ml of ice cold, sterile calcium chloride buffer (50 mM CaCl2, 
10mM Tris-HCl, pH 8.0).  
 All suspended samples were left on ice for 15 minutes, next they were centrifuged at 
10,000 rpm for 1 minute at room temperature. The supernatant was discarded and the cells 
were re-suspended in 1/15 of the original volume (66 µl) of ice cold, calcium chloride 
buffer solution.  
2.23 Transformation  
 
This step allows the plasmid harbouring the gusB gene to be taken up by the competent E. 
coli cells; antibiotic selection was used to increase the chances of non-specific 
transformation. A positive control containing pTTQ18 and pMJB33 was also set up during 
the experiment to test their transformation efficiency.  
5-10 µl of plasmid DNA was added to 200 µl of competent cells kept on ice; all samples 
were placed back on ice for 30 minutes. Next, samples were heat shocked at 42°C for 2 
minutes on a heating block to encourage uptake of DNA, then returned to ice box 
immediately for 1-2 minutes. 330 µl of LB media was added to the samples, all micro 
centrifuge tubes were placed in a flask making sure they were tightly shut and placed in the 
orbital shaker at 37°C to at 250 rpm for 1 hour.  Ampicillin containing plates were dried in 
the incubator during this time, once dry 200 µl of the cells was pipetted onto plates and 
spread using an L shaped spreader. The plates were then be placed upside down into an 
incubator and left to grow over night at 37°C.   
2.24 Assay to test transport of the Glucuronide Transporter Protein 
(GusB)  
 
2.24.1 Pilot test: time course  
 
This assay helps to determine the time it takes for both gusA and gusB to be induced, 




of how long it is before background GusA activity occurs when pNPG is added. Prior to 
this experiment, overnight cultures of different E. coli strains were set up in LB media 
containing ampicillin (100 l/ml). For each separate strain one colony was added into a 
flask (flasks promote better cell growth than falcon tubes) containing LB media. All the 
above steps were conducted using a flame to reduce the risk of contamination.  
Flasks were placed into the orbital shaker at 250 rpm and at 37˚C for around 16 hours.  
With all successfully grown strains, 200µl of the sample was added into 20ml of LB 
containing ampicillin. The samples were then placed back into the orbital shaker at 37˚C 
for 3 hours. IPTG (1 mM IPTG final concentration) was added to just one of each of the 
samples and set to shake for one hour in the orbital shaker.  For each sample, 0.5 ml was 
added into a 1.5 ml micro-centrifuge tube containing LB and 0.5 ml into a 1.5 ml micro-
centrifuge tube containing Sodium Carbonate (NaCO3, 1 M) that were put straight onto 
ice.  
p-nitrophenyl-β-D-glucuronide (pNPG) was added to all remaining samples. At the 
following times 0.5 ml of each sample was taken and pipetted into a micro-centrifuge tube 
containing LB and 0.5 ml into a micro-centrifuge tube containing NaCO3 and put on ice:  
2 minutes  
5 minutes  
10 minutes  
15 minutes  
20 minutes  
 After time course had ended, a NaCO3 blank was added to a cuvette and put into the blank 
slot on the absorbency spectrophotometer. All samples containing NaCO3 were first put 
into the centrifuge at 13,000 rpm for 1 minute to precipitate DNA cells at the bottom of the 
tube. All samples from the centrifuge were removed and using the supernatant all samples 
were measured at A405.  
Once measure the DNA precipitate was re-suspended in LB media using a vortex. Once re-
suspended the samples were pipetted one by one into cuvettes and measured at A600. The 
blank in the spectrometer was changed from NaCO3 and instead LB was used. All samples 







2.24.2 Transport test using differing p-nitrophenyl-β-D 
glucuronide (pNPG) concentrations.  
 
To work out the Km Vmax values and to determine binding affinity for the mutated gusB 
transport tests using different concentrations of pNPG concentrations were tested using 
spectrophotometry. OD600 was used to measure bacteria concentration and OD405 
measures cleaved pNP from pNPG concentration. 
Cells from plates containing pTTQ18, pMJB33 and pE349A plasmids respectively were 
inoculated in 15 ml of LB media containing ampicillin; they were put into the orbital 
shaker at 37°C for 16 hours to promote cell growth.   
If the cells have grown adequately overnight, the culture was re-inoculated in 20 ml of LB 
with a 1 in 30 dilution. There were two samples set up for each strain at this point, to one 
of each IPTG was added at a 1mM concentration and these were placed back into the 
orbital shaker under the same conditions for a further 3 hours.   
Once cells have grown in the media and protein expression has been induced by IPTG, six 
different falcon tubes should be assigned to each sample with pNPG concentrations of 
0.25, 0.5, 0.75, 1 and 1.5 mM. pNPG was then aliquoted to each sample with a final 
volume of 3ml.   
Once the pNPG was added, all samples were left for 15 minutes. 500 µl of each sample 
was added into 500µl of 1M Sodium Carbonate (NaCO2), this will lower the pH and stop 
the GusB from cleaving the pNPG. Another 500 µl of each sample was added into 500 µl 
of LB media. All were put into the centrifuge for 2 minutes to precipitate the DNA.   
The supernatant from all samples containing NaCO3 was transferred to cuvettes and PNP 
concentration was measured at 405nm using the Shimadzu UV-1800 Spectrophotometer. 
For samples intended to measure the bacterial concentration using, the flow through 
containing LB was discarded, and making sure the DNA was not removed. 1 ml of fresh 
LB was then added, the cells and they were suspended using the vortex. All samples were 
transferred to cuvettes and this was measured at 600 nm.    
 
2.24.3 p-nitrophenyl-β-D-glucuronide (pNPG) test for standard curve  
 
A p-nitrophenyl-β-D-glucuronide (pNPG) test needed to be set up to allow for comparison 
with samples from the transport tests. When pNPG is cleaved into PNP it creates a 
chromogenic response. The E. Coli strain (MC1061) used to transform these clones did not 




the mutant GusB has likely been taken up. Transport results for functionality can then be 
compared to the Wildtype and negative control (pTTQ18). 
pNPG was diluted to at the following concentrations: 10, 20, 50, 100, 200 and 500 nM into 
1 ml LB solutions. These were all left for 15 minutes. 500µl of each was then added to 1M 





























3. Results  
 
The overall aim of this project intended to find residues within the GusB protein that were 
significant to molecular recognition. To achieve this aim, success at each stage of the 
cloning section is imperative. Oligonucleotide primers were designed to introduce site 
specific mutations into the GusB sequence, PCR was then used to amplify DNA products 
containing the mutations. Restriction digest was completed to cut the insert and plasmid 
DNA (pTTQ18) so the amplified DNA fragment could then be inserted into the plasmid 
during ligation. Finally, the plasmid be introduced into competent E. coli cells in the 
transformation stage and cells containing the modified plasmid can be harvested. If 
transformation is successful within the MC1061 E. coli strain, this will allow transport 
assays to be conducted and after mini prep clones can be sent for sequencing to confirm if 
mutation within the sequence was successful. 
This section will detail all the results obtained throughout the cloning process. Variations 
in procedures at each step were introduced to optimise the results for each procedure. 
 
3.1 Amplification of DNA fragments using the Polymerase Chain Reaction 
(PCR)   
In order to generate mutants, a forward and reverse primer must first be amplified in this 
step of the cloning process. Successful amplification of DNA in lanes 2, 3, 4, 7 are seen 
below in Figure 3-1. Both forward and reverse DNA fragments for the mutation based at 
position L119C of the gusB gene (identified by the green arrows) were amplified and 


















Table 3-1. Expected molecular weight (bp) of mutated DNA fragments using designed 
forward and reverse primers after PCR amplification. All results could be compared to 
this in order to see if the bands corresponded to the expected weight in order to see in 
specific amplification has occurred. This can be seen on a DNA ladder when samples are 
run on agarose gel electrophoresis. 
Name of Mutation Expected Molecular Weight 
of Forward primer (bp) 
Expected Molecular Weight 
of Reverse Primer (bp) 
TM1G27D 1304 89 
TM4L119C 1026 369 
TM6H183E 839 558 
TM8N273D 558 839 
TM10E362N 352 1040 




 Figure 3-1 Electrophoresis results showing products yielded from primary PCR, the 
arrows represent bands for different DNA fragments. Results can be seen for samples 
loaded in lanes 2 (Red arrow=Tm1G27DR), 3 (Green=TM4L119CF), 4 
(Green=TM4L119CR), 7 (Yellow=TM8N273DF) and 11 (Pink= TM12R406EF). Samples 
in lane 3 and 4 are the only PCR products representing corresponding forward and reverse 
DNA Fragments. Gel: 1.2% agarose, 70V, 40 minutes.  
 
As a means of troubleshooting to achieve amplification for other mutagenic primers, 
different concentrations of pMJB33 plasmid DNA were tested (1 pM, 10 pM, 100 pM, 1 
nM, 2.4 nM) to see which produced the clearest band, this would show the optimum 




fragment was was amplified using primer ER1gusBF amd KpIgusBR as seem in Table 2-2. 
Lane 3 shows smearing and multiple bands which could mean contamination of the 
samples or non-specific binding. The results showed that pMJB33 template DNA with a 
concentration of 10 pM was most suitable (as seen in Figure 3-2).   
 
Figure 3-2. PCR amplification for pMJB33 at differing concentrations. Plasmid 
template DNA can be seen in the following: Lane 1=2.4nM 2=1nM 3=100pM 4=10pM 
5=1pM. The molecular weight of gusB is around 1.4kB therefore it is expected that the 
desired products will be seen at 1.4kB. The clearest band can be seen using 10pM 
concentrations of template DNA in the PCR reactions mix.  
Gel: 1.2% agarose, 70V, 40 minutes.  
 
 After making the changes above and also increasing the concentration of primer DNA to 
0.4 µM, amplification of other the other mutated DNA fragments plus the initial PCR 
products was achieved. Although the dNTP concentration was too high, the amplified 
forward and reverse mutagenic primers for the following samples could be used in fusion 
PCR: pAB-G27D (lanes 1, 2) pAB-L119C (lanes 3, 4) pAB-H183E (lanes 5, 6) pAB-





 Figure 3-3 Third attempt at primary PCR amplification, lanes represent: 1=TM1F, 
2=TM1R (shown by red arrows), 3=TM4F, 4=TM4R (shown by green arrows), 5=TM6F, 
6=TM6R (shown by purple arrows) 7=TM8F, 8=TM8R (shown by yellow arrows). The 
last 4 lanes are TM10F (blue arrow) and R and TM12 F (pink arrow) and R, the lack of 
results may be due to conditions not being optimal or an issue with the reaction mix. These 
samples were not used in the next stage, fusion PCR. Gel: 1.2% agarose, 70V, 40 minutes.  
 
 
Figure 3-4 Second set of amplification results for primary PCR to yield more stock of 
products for the next stage in the cloning process (as above) lanes represent: 1=TM1F, 
2=TM1R (shown by red arrows), 3=TM4F, 4=TM4R (shown by green arrows), 5=TM6F, 
6=TM6R (shown by purple arrows) 7=TM8F, 8=TM8R (shown by yellow arrows). Gel: 





3.2 Amplification of fused gene fragments using fusion PCR  
 
Before fusion of DNA fragments is attempted, primary PCR products must first be treated 
with the enzymes DpnI,  this will target any unwanted methylated DNA within the reaction 
mix. PCR products do not have methylated DNA and therefore will not be affected, this 
will increase the purity of the sample (Chen and Janes 2002). The template plasmid 
originates from the Dam+ E. coli strain MC1061; this means they have methylated 
adenines in any GATC sequences on the plasmid. When the PCR products are digested 
with DpnI, only the non-mutated and methylated templates will be eliminated meaning the 
desired mutated plasmids only are left in the solution increasing purity (Palmer and 
Marinus 1994). In fusion PCR 5' forward and reverse gusB primers as well as 3' forward 
and reverse primers were added to the solution. For each, desired mutagenic fragments 
were added also added to the reaction mix along with corresponding flanking primers, this 
meant that the whole of the double stranded DNA fragment encoding each site-directed 
mutation would be amplified.  
After primary PCR products were purified using Sepharose (Section 2.13), corresponding 
DNA fragments were added to the reaction mix for the second round of PCR amplification. 
Fusion of the DNA fragments can be seen in lane 1 at 1.4 kb which is the size of the gusB 
gene. The bands on the gel in lane 2(TM4L119C), 3(TM6H183E) and 4(TM8N273D) 
show non-specific amplification. Smears above such as the one seen in lane 3 may indicate 
too much MgCl2; smears below the products may indicate too much plasmid DNA was 
added to the reaction mix. The non-specific bands observed may be due to inaccurate 








Figure 3-5. Second attempt (2nd step) PCR amplification to achieve gene fusion of 
sample fragments, Fused PCR products  can be seen in lane 1 which is the expected size 
of  the gusB gene (1.4 KB). This fragment could is expected to contain mutation 
TM1G27D (represented by the red arrow). Non-specific amplification can be seen in lanes 
2-4. The multiple bands may be due to the annealing temperature being too low resulting in 
non-specific binding of primers to the target DNS sequence. Gel: 1.2% agarose, 70V, 40 
minutes. 
 
After multiple attempts resulted in non-specific amplification, primer sequences were 
checked to see if they correctly encoded gusB as well as checking that the 5' and 3' forward 
and reverse primers of each were complementary. This should have been checked prior to 
beginning the experiments; however this was a learning point in this project. These 
concluded sequences were as expected and troubleshooting of fusion PCR continued. The 
annealing temperature of both forward and reverse primers differed for each and therefore 
a gradient PCR was set up, this enabled the fragments to react at the optimum temperature. 
Also, primer which were non-diluted and 5X diluted primers were used for PCR in order to 





Figure 3-6 Fourth attempt 2nd stage PCR amplification: Lanes 1-4 show PCR fusion 
attempts with concentrations of 1mM template DNA. Non-specific amplification of 
primary products can be seen however some fusions has occurred which are all expected to 
be 1.4kB. The right size products can be seen in lanes 6 (red TM1G27DF+R), 7 (green 
TM4L119CF+R), 8(purple TM6H183EF+R) and 9 (yellow TM8N273DF+R) show 
primers with concentrations of 0.2 µM. Fusion occurred for all four products; non-specific 
amplification still occurred however fusion bands are clearer. Smears above show too 
much MgCl2 was added and the amplification of non-specific products and smears below 
show primers should be more diluted. Gel: 1.2% agarose, 70V, 40 minutes  
 
Fusion PCR using primers with a concentration of 0.2 µM show successful amplification 
of products using gradient PCR temperatures and conditions required for each set of primer 
(see Figure 3-6). The conditions were not optimal, however the bands seen do represent 
fused products. Using results from this experiment in addition to products previously 
yielded using primer concentration of 0.1µM (see in Figure 3-7) gel extraction could be 
performed. This allows isolation of fused DNA fragments (1.4 kb) from unwanted products 
in the solution. All products or bands with a molecular weight of 1.4 kb were presumed to 
be the mutagenic versions of the gusB gene, sequencing results could determine this in the 








































                          
Figure 3-7. Fifth attempt at 2nd step PCR amplification: lanes 1-4 (1. TM1G27D, 2. 
TM4L119CF, 3. TM6H183E, 4.TM8N273D) show 1/8 diluted primers with a 
concentration of 0.125 µM; lanes 5-8 (5. TM1G27D, 6. TM4L119CF, 7. TM6H183E, 
8.TM8N273D) show 1/10 diluted primers with a concentration of 0.1 µM and 9-12 (9. 
TM1G27D, 10. TM4L119CF, 11. TM6H183E, 12.TM8N273D) show 1/12 diluted primers 
with a concentration of 0.08 µM. Fusion occurred in lanes 4, 7, 8 and 12. Smears still 
indicate primers were too concentrated and MgCl2 concentration was too high.  
  
Figure 3-8. Amplification of already fused PCR products using 0.2 µM and 0.1 µM 




products underwent a second round of PCR amplification to yield as much product as 
possible for the next stages of the cloning process. DNA concentrations of 0.2 (top gel) and 
0.1 µM (bottom gel) were used in the reaction mix, increased annealing temperatures were 
also used for all reactions. Due to human error, some lanes show no bands . TM1G27D 0.2 
µM= lane 2, 6 and10 for the top gel and TM1G27D 0.1 µM= lane 3 on the bottom gel. 
TM4L119C 0.2 µM= lane 3, 7 and 11 on the top gel and TM4L119C 0.1 µM= lane 4 and 5 
on the bottom gel. TM6H183E 0.2 µM= lane 4, 8 and 12 on the top gel and TM6H183E 
0.1 µM= lan9e 6 and 7 (no results) on the bottom gel. TM8N273D 0.2 µM= lane 5, 9, 13, 
14 & 15 (no product amplified in lanes 13, 14 and 15) on top gel. TM8N273D 0.1 µM= 
lane 8 and 9 on the bottom gel. Please note: Lane 1 contains the ladder on both gels. 
  
3.3 Purification of gene fragments using the gel extraction method  
 
After successful fusion was achieved agarose gel extraction was carried out as a means of 
DNA purification as seen in Section 2.14. Purification using the Qiagen PCR Purification 
kit was previously carried out however this provided little success and with the presence of 
primary products still in the reaction mix gel extraction was necessary.  
After fused products were extracted using the gel extraction method, electrophoresis was 
conducted to see how much DNA had been recovered. Bands showing fused products at 
1.4kb could only be detected for two samples as seen in Figure 3-9, this showed that a lot 
of the DNA from fusion PCR had been lost in the extraction and purification process. This 
was also confirmed in concentration determination; Nanodrop readings seen in Table 3-2 
showed less than 1 ng/µl was present for each of the samples which indicated why the 
bands were not visible on the gel. For the next stages of the cloning process 5 ng/µl of 
DNA is required, therefore by using increased volumes of DNA, cloning could continue. 
Bands were visible for samples possibly containing mutations TM1G27D and TM8N237D. 






Figure 3-9. Purified products after gel extraction treatment: bands can be seen in lane 
1 and lane 12 showing fused gusB products (the red arrow identifies TM1G27D and the 
yellow arrows identify TM8N237D). Lane 13 shows PTTQ18 cut with KpnI and lane 14 
shows PTTQ18 cut with EcrI (orange arrows). The other lanes also contain samples 
however, after purification DNA concentration may be too low to see bands.   
 
Table 3-2 DNA concentration of samples 1-6 using Nano-Drop 2000 technology after 
purification by the agarose gel extraction method, samples were tested to find out DNA 
concentration. This was to find out how much was needed for the ligation mix in the next 
stage of the cloning process. 
Sample  Concentration of DNA 
(ng/µl)  
Approximate amount needed 
for ligation (µl)  
1: pAB-G27D  0.6  9  
2: pAB-L119C  0.1  50  
3: pAB-H183E (1)  0.2  25  
4: pAB-N273D (1)  0.9  6  
5 pAB-H183E (2)  0.2  25  
6: pAB-N273D (2)  0.7  8  
  
3.4 Restriction Digest, Ligation and Transformation of clones  
 
Once purification of PCR products has been conducted both the mutagenic DNA fragment 
and plasmid expression vector pTTQ18 (map can be seen in figure 2-2) needs to be 




expression vector. The PCR products underwent double digest with both with KpnI and 
EcoRI for 3 hours.  pTTQ18 was first treated with KpnI then EcoRI (both high fidelity 
enzymes). Most enzymes can be inactivated via incubation at around 65-80°C for 20 
minutes. However, this does not apply for KpnI therefore pTTQ18 and the DNA fragments 
had to be treated with phenol and purified using ethanol precipitation. Ligation was then 
completed.  
After the above steps were taken transformation was attempted using procedures to make 
competent E. coli MC1061 cells (see Section 2.22) and using already competent 
commercial E. coli cells: DH10-β and DH5-α (Table 2-1). Two controls were used, a 
positive control: undigested pTTQ18 as a negative control: and non-ligated pTTQ18 cut by 
restriction enzymes and dephosphorylated. The first attempt did produce any results. 
 
Purified DNA fragments and the expression vector pTTQ18 were re-ligated and the correct 
positive control was used to test transformation efficiency. However, once again, 
transformation was not successful, and the controls were not effective which may indicate 
issues with the plates themselves. This led to beliefs that the concentration of ampicillin 
used for the plates may have been too high. New plates were made 1/1000 dilution of 100 
mg/ml ampicillin. As a means of troubleshooting both pTTQ18 and pMJB33 were 
transformed with competent 5-aplha and 10-beta E.coli cells. A table showing details for 

















Table 3-3.  Template DNA (pMJB33) and plasmid vector (pTTQ18) used in this 
project. Both were used as positive controls in transformation. Following information 
regarding genotype can be found below:  
Plasmid name  Plasmid Information  Source  
pTTQ18  > pTTQ18 Expression vector; 
Ptac bla        
tac promoter, rrnB 
transcription terminator, 
polylinker and lacZ alpha 
fragment from pUC18, and 
lacIQ gene 
(See figure 2-2 for plasmid 
map) 
(Stark, 1987)  
Based on pUC18 vector from 
E. coli.  
pMJB33  >WLI69590_03_CP2 
(pMJB33_100R_I23  
 (See figure 2-1 for plasmid 
map) 
(Bruce and Liang 2014)  
Wildtype plasmid containing 
only functioning gusB from 
E. coli  
   
  
Figure 3-10. Transformation of pMJB33 and pTTQ18 in competent DH5α E. coli 
cells From New England Biolabs. Single colonies of E. coli bacteria can be seen on both 
plates which indicated that successful transformation occurred for samples pMJB33 and 





The results showed that DH5-α E. Coli cells were competent as single colonies can be 
seen, therefore the problem lies elsewhere. Transformation efficiency was still very low. In 
this case the most logical cause for failure to transform the mutated clones would be that 
ligation did not work, this is likely as there was only a small concentration of DNA after 
purification. In addition to this, if any of the ends were left nicked and the plasmid had not 
circularised, then no colonies would be seen (Welsh et al, 2016). The 10-beta cells on the 
other hand showed no colonies for pTTQ18 or pMJB33 positive controls, these cells were 
previously used by other students and the stock was old which could mean degradation or 
contamination had occurred before use in this project.  
 
3.5 Sequencing of clones  
 
Samples of the E. coli colonies potentially harbouring pTTQ18 with mutated gusB were 
sent off as well as purified products from successful PCR products. Unfortunately, the 
qualities of the samples were very poor deeming them unsuitable for sequencing purposed. 
A previous gusB clone named pE349A, 349 referring to the position of the point mutation, 
was sent for re-sequencing due to unexpected transport activity. Sequencing results showed 
a second mutation at position 218 changing the Asparagine amino acid to Lysine.  
 
3.6 GUS Assay  
 
Although transformants of clones designed for this project were unsuccessful, previous 
clones obtained by Dr Wei-Jun Liang and past students in the lab were tested against each 
other using GUS assay transport tests (Little et al, 2017). In addition to this negative 
control: pTTQ18 which does not contain the GUS operon and a positive control: wildtype 
E. coli strain pMJB33 which has a functional gusB gene were used. By doing these 
transport assays, it is possible to assess whether any of the site directed mutations are 
structurally relevant to the molecular recognition site within the protein. Changes to 
transport compared to the wildtype (pMJB33) would suggest it is. 
All clones were transformed into MC1061 E. Coli strains with abolished gusB activity 
therefore; very little background activity should be seen. 
 A405 results show the absorbency of the sample against the blank and A600 measures the cell 





Table 3-4. Cell Count and Absorbency test measured using absorbency at A405 and cell 
count at A600 for six samples. pTTQ18 does not contain gusB and therefore is the negative 
control. pMJB33 does contain a functioning gusB and is the positive control. All other 
strains are mutated strains from past student projects working on the gusB gene. Transport 
of glucuronide substrates for all clones had decreased compared to the wildtype. This was 
expected however, the decrease in absorbency for pR210G contradicted past results. 
 
Sample name  Absorbency (A405)  Cell count (A600)  
pTTQ18  0.04  0.53  
pMJB33  0.77  0.59  
pP100A  0.07  0.44  
pE349A  0.06  0.38  
pR210G  0.29 3.46 
 
3.6.1 p-nitrophenyl-β-D-glucuronide (pNPG) transport test  
 
When iPTG and pNPG wer added to LB containing clones, the gus gene would be 
transcribed and both transport by GusB and cleaving by GusA would occur producing a 
chromogenic response (a yellow colour). A more vivid yellow will indicate a higher 
concentration of cleaved pNPG in the solution and the absorbency value will also increase. 
All clones showed a lower absorbency than the wildtype plasmid pMJB33, which may 
indicate that the transporter protein is not working as efficiently for the mutants in 
comparison to the natural isolate as seen in Table 3-4. Some of these results were 
unexpected since pR210G, a gusB mutant plasmid, had previously produced results 
showing increased rate of transport when tested with X-Gluc however, as seen in the table 
when tested using pNPG the transport had decreased by over half. pP100A, also a mutated 
GusB plasmid showed transport rate significantly lower than pMJB33 and activity seemed 
to completely diminish in comparison to the wildtype. In previous unpublished tests this 
mutation resulted in a significant increase in the activity therefore results obtained here 
were questionable. After repeats, similar findings were observed therefore, all plasmids 
from previous gusB projects were sequenced. pR210G and pP100A sequencing showed the 
samples used only contained vector DNA and therefore were not true transformants. With 
gusB not present within vector DNA, this explained the low absorbency for the pP100A 
plasmid. The reading for pR210G may have been because of background activity. 
A new mutation changing Asparagine to Lysine at position 218 of the gusB gene in 
pE349A (See Appendix 5) could possibly have links to the molecular recognition site, with 




the membrane despite having the gusB gene which creates the presumption that the residue 
mutated could be essential for molecular recognition or binding.  
 
3.6.2 GUS Assay time course: pilot experiment  
 
Just taking the A405 and A600 readings was not enough to identify if the molecular recognition 
site of any of the proteins had been changed or if transport had been affected. A time 
course was set up in which the reaction was stopped at a number of time points from 0 
minutes to 20 minutes to determine at which time point transport was most efficient (see 
figure 3-11). It was found that transport between 10-15 minutes was optimum. This 
allowed the next part of the assay to be conducted, which would then determine the 
binding affinity for each different sample. To determine the optimum time the calculation 
below was done. 
 
  
Figure 3-11. A graph to show the transport activity of different samples containing a 
mutagenic GusB at five time intervals. The most dramatic differences in transport 
activity occur at the 10 and 15-minute mark therefore this should be how long samples are 
left, this represents the peak time taken for both GusA and GusB to be transcribed and for 
pNPG to be transported into the cell and cleaved. pMJB33 from the unpublished work of 
Bruce and Liang was used as a positive control as this contains the wildtype gusB. pTTQ18 
was used as a negative control and would be expected to show the least activity due to no 
functional gusB. The other clones represent those from the unpublished work of Qi Wei 
Yao (2015). This will be used in the next stage of the GUS assay.  
 
The results show that the most dramatic changes in transport occur from the 10 to the 15 







3.6.3 pNP concentration test for standard curve  
 
Results from pNPG transport tests showed that an increase in pNPG transport also created 
an increase in absorbency (A405). Using the equation as seen below, linear regression was 
calculated using the data points. This will allow comparison of A405 Absorbency readings 
from this data set and for pTTQ18, pMJB33 and pE349A results in Section 3.6.4 so that 








Figure 3-12 Samples containing different concentrations of pNP for standard curve. 
The samples range from left to right show: 10 nM, 20 nM, 50 nM, 100 nM, 200 nM and 
500 nM of pNP. pNPG substrates are transported by GusB across the cell membrane and 
are cleaved by GusA. This produced a chromogenic response, the yellow colour becomes 








Figure 3-13 pNP standard curve graph showing linear regression. As concentration 
(1=10 nM, 2=20 nM, 3= 50 nM, 4= 100 nM, 5=500 nM) increases absorbency (A405) also 
increases. A405 is the measure of pNP therefore this reflects the concentration of the 
cleaved glucuronide substrate. The equation for the line of best fit is y= 0.6639x – 0.7551  
 
3.6.4 GUS Assay: optimal pNPG concentration determination  
 
 After 3 hours of induction by IPTG (for all + samples), pNPG was added to each sample 
at concentrations of 0.25 mM, 0.5 mM, 0.75mM, 1 mM and 1.5 mM. This was the left for 
15 minutes, this was the time at which transport was found to be most efficient in the pilot 
study (Section 3.6.2). After converting the concentration of pNPG to nM using the 
standard curve graph the results showed that the wild type pMJB33+, which was used as a 
positive control, had the most efficient binding efficiency and rate of transport showing 
highest absorbency readings. The pTTQ18 results indicated very little transport had 
occurred, small amounts of background activity was seen shown by a low absorbency 
(A405) reading. pE349A showed even less transport efficiency than pTTQ18 despite the 
presence of gusB in the genotype.   
The first peak highlighted on Figure 3-18 could possibly show the Vmax for GusB binding 
which means GusB becomes saturated at 0.25-0.3 nM. After this point it is thought that the 
transporter had already reached its full capacity therefore adding more substrate could 
cause adverse effects. The second peak and rise in absorbency may be due to the cell 




of pNPG. GusA would still cleave the substrate however this is not representative of the 
transport of GusB. 
 
  
Figure 3-14. A graph showing the absorbency of samples pMJB33 +/-, pTTQ18 +/- 
and pE349 +/- with differing pNP concentrations. For all ‘+ samples’ pNPG was added 
to the reaction mix. All ‘– samples’ were used as a negative control as a means of 
comparison, these contained no pNPG within the reaction mix. Coloured lines represent 
different samples as seen in the key. pMJB33+ containing the wildtype GusB shows the 
highest absorbency readings meaning it had the highest concentration of pNP substrate 




















4.1 Findings presented in this study 
 
Substrate specificity for the glucuronide membrane transport protein, encoded by gusB, 
presents an interesting subject due to its ability to recognise such a broad variety of 
substrates. Not only this, but binding affinity for some glucuronide substrates have been 
found to be higher for some in comparison to others (Stoebar 1961; Liang, et al., 2005). 
The answer is thought to be related to the structure of the molecular recognition site. 
Some structural evidence related to the GusB protein has been published by Liang et al 
(1992 & 2005) predicting it to be made up of 12 trans-membrane helices such as those 
within the Major Facilitator Superfamily (MFS), however nothing which is able to identify 
the location or transport mechanism of the molecular recognition site. By looking at the 
protein at a primary structural level, key amino acid residues and interactions between 
these could be investigated. TM1G27D s was chosen after reading a paper by Madej et al 
2014, alignment was conducted against GusB showing a 19.8% identity (See appendix 8). 
The paper suggested the amino acid at position 27 was potentially important in substrate 
binding therefore this residue was changed for GusB.  
The other point mutations were chosen at random, GusB has relatively low sequence 
identity to those MFS transporters whose structures are known however, with the 
knowledge gained in this project more educated choices could have been made. For 
example, published evidence relating to binding and molecular recognition sites for MFS 
protein such as MelB and LacS should have been researched thoroughly. Using alignment, 
similar residues could then have been changed in GusB.  
On the other hand, regardless of sequence homology and categorisation all proteins 
function differently and the amino acids that were substituted could have indeed been 
relevant for molecular recognition. 
 The introduction of these six mutations was attempted using primer design and molecular 
cloning processes, in which amino acids with varying properties would be substituted for 
another. Each one of these mutated DNA fragments was then amplified using the PCR 
amplification method. The forward and reverse fragments were then fused and amplified 
once again in the second stage of PCR. DNA products for mutations at position 27 and 273 





Other studies have been conducted focussing on the effect of site directed mutagenesis on 
proteins within the MFS (Bannam et al., 2004; Lewinson et al., 2006; Holyoake and 
Sansom 2007). One particular study by Antala et al., (2015) aimed to use SDM to decipher 
whether mutations affect the kinetics or the selectivity of ZIP protein, the human zinc 
transporter (hZIP4) and in turn whether this had any effects on the transport mechanism. 
Like GusB, hZIP4’s structure is predicted to have 12 trans-membrane helices and too has 
been linked to the MFS. Findings from this study showed an amino acid change from 
Histidine to Alanine at positions 379, 507 and 536 altered the Km, Vmax and also the 
substrate specificity. It also was suggested that different amino acid interactions were 
responsible for specificity of different substrates. In fact, within ZIP member proteins, 
residues which make up the coordination site are variable and amino acid differences 
within the site were thought to contribute to differing cation specificity amongst the ZIP 
transporters (Antala and Dempski., 2012; Dempski, 2012) 
. 
Another study by Lee et al., (2015) also focussed on a protein categorised within the MFS, 
Synaptic vesicle glycoprotein 2A (SV2A). In order to understand the transport mechanism 
and binding characteristics of the protein in regard to racetam drug substrates, site directed 
mutagenesis was again conducted. It was found that a mutation at position 670 in the 
protein resulted in a complete loss of binding and therefore transports ceased deeming this 
structurally relevant for substrate binding and recognition however despite a 15% shared 
identity, position 670 shows as a gap in the sequence at this position (See appendix 9). 
They identified this position using sequence conservation analysis and molecular dynamic 
modelling which enabled them to suggest further residues that could line the binding 
pocket, these were later confirmed experimentally. 
 It would have been logical then to conduct more alignments with other MFS proteins and 
create changes at equivalent positions within the GusB sequence.  
Still, these studies prove that even one site-specific mutation can have drastic effects on the 
recognition, binding affinity and transport of specific substrates (Alegre et al., 2016). It 
was expected then, that creating mutations in GusB might also produce similar results. 
Differences in binding affinity and transport of glucuronide substrates once amino acid 
substitutions were introduced were therefore predicted if the cloning process had been 
successful. Using the PyMOL software by Schrödinger an up to date model was made 
which predicts the 3D structure of GusB, this included a key to show where substitutions 




Although the mutated DNA fragments designed for this project could not be transformed 
into E. coli strains. A plasmid containing a mutation in position 349 of the gusB gene 
produced interesting result. In an unpublished study by Qi Wei Yao (2015) supervised by 
Dr Wei-Jun Liang, transport tests using chromogenic X-gluc showed that the transport 
activity remained like that of the wildtype plasmid pMJB33 containing a fully functioning 
gusB. However, when different transport tests were done in this study activity had almost 
completely diminished. This raised concerns that contamination may have occurred or, this 
may not be the correct sample. The pE349A plasmid was sent off for sequencing; the gusB 
gene sequence still existed on the plasmid and included the mutation at the expected 
position. However, this wasn’t the only change to be observed, a mutation had also 
occurred at position 218 changing Asparagine (uncharged) to Lysine (charged) (See 
Appendix 5).  
Looking at alignment with XylE, the equivalent position of the 218 residue does not show 
homology and current literature does not reveal this to be particularly important for 
molecular recognition. The MelB alignment which showed a 27% identity with GusB does 
not show any sequence homology at this exact spot however; the three following amino 
acids in the sequence are identical (See Appendix 10). The literature and studies relating to 
the binding site of MelB however do not yet identify these to be actively important in 
molecular recognition or the binding site (Ethayathulla et al., 2014). However, this could 
be studied more closely in future work. In addition to this the sequence alignment 
conducted against SV2A showed sequence homology at position 218, although like MelB 
no current research names this as an important residue for molecular recognition this again 
should be studied further. 
 
Additionally, in the research by Qi Wei Yao (2015), transport activity in another of his 
clone’s pR210G also showed a drastic reduction in transport for X-Gluc. This was in line 
with results obtained in this project from pNPG Gus Assay (see Table 3-4, Figure 3-11). It 
was concluded in Qi’s research that the R210G mutation have created a change to the 
molecular recognition site, especially due to there being charged amino acids in the 
surrounding area. This would explain the changes in transport. The mutation found at 
position 218 is extremely close to this position. 
If Qi’s assumptions were correct this mutation would explain the changes in transport 
activity during GUS assay. Such a dramatic change in transport after the inclusion of a 




relevant to the molecular recognition site, and to the transport of p-Nitro-Phenol-
Glucuronide substrates. It could also be possible that having two mutations at position 349 
and 218 simultaneously within the gusB gene caused too much disturbance in the final 
structure of the translated protein and this upset molecular recognition and in turn transport 
activity.  
Looking at literature published for other MFS proteins similar to GusB, such as XylE, 
MelB and LacS, it does not appear that there are any relevant residues at this exact location 
however further alignments could help map this mutation to see if a relationship could be 
seen.  
Another thing to consider is that for proteins to work effectively it is important that they 
are translocated to the correct location within the cell. During or after protein translation 
has occurred within the cytosol, the protein must be translocated to their desired position in 
order to function effectively (Mori and Ito 2001). This is achieved due to the presence of 
signal sequences within the amino acid chain which act as directions to their final 
destination (Schatz and Dobberstein, 1996; Driessen and Nouwen 2008). It is possible then 
that the introduction of mutations to the amino acid sequence could result in proteins not 
reaching the correct position within the cell (Wickner and Schekman 2005).. For this 
project in particular, it is possible that the lack of transport in the assays could be due to 
disruption to the signal peptides rather than the molecular recognition site of GusB. This 
would mean that the glucuronide transporter may not have reached the cell membrane and 
therefore the transport of glucuronides would have been impossible (Rapoport 2007).  
 
Because of time constraints, further investigation as well as transport test repeats using 
positive and negative controls could not be carried out therefore it is suggested that this is 
repeated in the future. 
 
4.2 Difficulties faced during the project 
 
Throughout the project several procedural based issues arose. This was especially true for 
PCR. Repetition and multiple troubleshooting attempts had to be conducted for failed 
experiments. Optimisation for PCR conditions is extremely important, therefore in order to 
resolve common problems (non-specific amplification, too high concentrations of DNA, 
primer and MgCl2 and optimal annealing and melting temperatures) PCR had to be done 




Later on in the project, it appeared issues with ligation had occurred due to no colonies 
being present on plates for mutated cells. However, positive controls did show colonies 
after transformation (See Figure 3-10). This may have bene due to incompatible DNA 
ends, damaged DNA or contamination or incomplete digestion, suggestions on how this 
could be identified will be covered in Section 4.4 (NG & Sarkar 2012). 
This was costly in terms of time and often halted the cloning process for long periods. 
Theoretically the methods used for cloning in this project should be simple, however 
adaptations of these needed to be made on numerous occasions specifically during DNA 
amplification. This meant the initial time frame was compromised and the later stages of 
cloning suffered as a result. In hindsight, contingency plans should have been put into 
place to account for this.    
4.3  Other problems faced 
 
Technical malfunctions with vital machinery caused huge problems throughout this study. 
This resulted in the cloning process being delayed.   
The PCR machine being used was unknowingly malfunctioning, during cycles the power 
would cut off and the machine would start again which meant many products were non-
specific and repeats of the procedure were necessary. This meant that the all PCR 
amplification methods that had undergone troubleshooting needed to be repeated.  
Other issues halted the cloning process which had not been considered prior to starting the 
project. Long delays for chemical orders meant there were long periods between 
procedures. In addition to this other vital equipment including the autoclave, vital for 
sterilisation, were out of use. This contributed to the lack of testable clones being 
produced. Even though extra time was given these factors proved to be a massive hurdle  
4.4 Methodology based problems  
 
4.4.1 Issues with PCR 
 
4.4.1.1 Amplification of primary PCR products: Problems and Troubleshooting 
 
Many processes carried out in the lab were repetitive however; this was particularly 
problematic for primary and fusion PCR. Although in theory the procedure should be 
simple, achieving optimum conditions to produce the desired DNA fragments proved to be 





Fused products were achieved for four of the samples visibly showing gusB DNA 
fragments at 1.4kb which is the expected size of the gusB gene. However, this was after 
numerous troubleshooting attempts. 
DNA amplification began using the PCR protocol in GUS protocols (Gallagher 2012) was 
followed containing a mix of flanking primer and mutagenic primers to produce six 
separate gusB mutants. After testing the amplification using gel electrophoresis, it showed 
that DNA amplification attempts were unsuccessful. The smearing of bands seen the 
bottom of the gel showed too much DNTP was added, this was then diluted in the next 
reaction from 20 µM to 15 µM. The absence of bands representing the mutated DNA 
fragments may be due to low concentrations of primer or plasmid template in the reaction 
mixture (Roux 2009). To obtain better results for all products, each component was added 
to the samples separately rather than by creating a master mix. This ensures the optimum 
concentration of each substance is present in the final reaction mix. Primers were re-diluted 
from stock samples again to a concentration of 0.2 µM. After these steps were taken PCR 
was successful for some of the samples. 
As a means of troubleshooting to achieve amplification for other DNA fragments from the 
remaining mutagenic primers, a new stock of dNTP was made to rule out the possibility of 
contamination or degradation of old stock. Also, plasmid DNA (pMJB33) was extracted 
and a fresh stock prepared. As some of the samples showed no result, primers were again 
re-diluted, to concentrations of 0.4 µM and all were mixed well prior to a third attempt at 
PCR using a pipette. This ensured the DNA was eluted within the solution. Changing the 
template DNA (pMJB33) concentration to the optimum of 10 pM also improved results 
(Section 3.1, Figure 3-3) 
 
4.4.1.2 Amplification of fused PCR products: Problems and Troubleshooting 
 
Fusion PCR came with several problems due to technical issues with the PCR machine as 
well as difficulties in creating the optimum conditions for amplification of fused DNA 
fragments. The first time 2nd step PCR was conducted no results were obtained at all. The 
reaction was conducted at 60˚C which may have been too high for some of the primers to 
anneal to the template seen as annealing temperature should be around 5˚C below Tm (See 
Table 2-2).  
In the next attempt, smears above products indicate that the MgCl2 concentration was too 




may indicate the concentration of DNA products from primary PCR was also too high 
(Owczarzy et al., 2008; Roux, 2009). This was reduced to 0.2 µM. The non-specific bands 
observed may be due to inaccurate annealing temperatures therefore gradient PCR using 
different temperatures was conducted with the aim of producing more specific fusions 
(Lorenz 2012). In addition to this purification of all DNA fragments from primary PCR 
was also repeated using sepharose. 
Troubleshooting was a lengthy process for second-step PCR, with concentrations being 
changed for each constituent many times. However, eventually fused DNA fragments were 
obtained when 0.2 µM of primer was used. When products were visualised the 
observations made, such as smearing, indicated the reaction mix still had volume and 
concentration issues. This again was related to and high concentrations of MgCl2 (Ruiz-
Villalba et al., 2017). 
Non-specific primer binding can be a frequent problem and can obscure PCR results. Due 
to the exponential nature of PCR, if primers bind to a non-specific site on the template 
DNA strand, this will be amplified in the following cycles and millions of copies of this 
fragment will be produced (Apte and Daniel, 2009). If this goes un-noticed it can lead to 
false positive results and the later stages of cloning will suffer because of this. 
To avoid this, the following steps can increase specificity of products: primers can be put 
into NCBI Blast along with the template strand to identify any other binding sites in the 
sequence; the amount of PCR cycles should be reduced; increase the annealing temperature 
as primers bind non-specifically as lower temperatures; lower the concentration of both 
primer and MgCl; Reduce the extension and annealing cycle times; Make sure that primer, 
template DNA, dNTP solutions and all other reagents are not contaminated; use the 
Touchdown PCR method starting at a higher temperature then lowering each cycle until 
the annealing temperature is reached (Hyndman and Mitsuhashi, 2003; Ruiz-Villalba et al., 
2011; Schoenbrunner et al., 2017; New England Biolabs, 2020). In addition to the 
inclusion of a positive to test if the primers are binding well and a negative control will 
show in any contamination is present.  
 
Troubleshooting could have continued for PCR to achieve optimum results with clearer 
more specific bands however, time restraints meant that the next stages of cloning were 
required. Extraction of expected DNA fragments with a molecular weight of 1.4 kb were 





4.4.2 Ligation and Transformation: Problems and Troubleshooting 
 
The final step in the cloning process, transformation, was the most problematic as none of 
the cloned samples showed any single colonies however the positive controls (uncut 
pTTQ18 and pMJB33) did. Still, transformation efficiency was relatively low and although 
it appeared the plates and competent cells were not the reason for lack of transformation 
this may have been a limiting factor (Liu et al., 2014; Nagamani et al., 2019). Problems 
with ligation could too be the cause of this failure, lack of DNA seen on the gel after 
restriction digest and phenol extraction may implicate a lack of DNA needed for this 
process even though only 5-10 ng is recommended for ligation reactions (Cranenburgh 
2004). A higher concentration of DNA should have been used to begin with and although 
the problem had potentially been identified time did not allow for the experiment to be 
repeated especially with small quantities of sample left to perform ligation. 
 
4.5 What would be done differently if given the chance 
 
Although some of the aims established at the beginning of this project were met, the main 
objective was not achieved. This raises questions regarding what could have been done 
differently in order to obtain the desired results. 
First and foremost, all mutations other than TM1R27D were randomly selected. In 
hindsight, this is not logical and more educated decisions could have been made. By doing 
alignments with similar MFS proteins such as LacS, MelB and FucP, amino acids with 
known functional relevance could have been targeted. Also, by applying current 
knowledge detailing important residues involved in molecular recognition, alignments 
would help to map which residues on the GusB protein are equivalent (Damián-Almazo 
and Saab-Rincón 2013). Mutations should have been made at these sites, if changes in 
transport were seen this can be compared to the other proteins.  
With the lack of experience at the start of the project, it seems the number of site directed 
mutations first established was too ambitious for the time frame. Six pairs of primers could 
have been reduced meaning less time was spent trying to achieve results in the early stages 
of the cloning process. For example, troubleshooting of PCR was attempted many times to 
try and yield results for each set of primers. It would have been more beneficial to the 




process to continue and all steps could have been completed including sequencing and 
meaningful transport tests.  
A more thought out contingency plan relating to each step of the cloning process would 
also have been beneficial especially for time management and efficiency purposes. This 
may have included a rule that after two attempts were made using the same methodology, 
this should be tweaked logically based on the prior results. Alternate methods could have 
also been researched and tested at certain points rather than continuous trial and error of 
the same procedure. 
In addition to this, each step of the cloning process is extremely sensitive; it would then 
seem advantageous to include both positive and negative controls at every point. A positive 
control is a control which is expected to work under the conditions that you are using in the 
experiment, if this does not work it indicates it is something wrong with the way the 
experiment is being conducted. If the positive control does achieve results but the test 
subject does not, then it shows the conditions are not ideal for this specific reaction and 
therefore this can be manipulated (Tubbs and Stoler 2009).  
For instance, in PCR reactions, if they positive control fails it can indicate something is 
wrong with the master mix, the temperature setting is unfavourable or annealing and 
extension times are not right for amplification of these samples. If, however a band is seen 
for this reaction but not for the other samples when visualized using electrophoresis, it 
could show a lack of or excess template (Banasik et al., 2016). 
A negative control should not give any results and it not expected to work, it is most 
commonly used to check for contamination within the cloning process (Sambrook and 
Russell 2001). For example, this could be bacteria colonies which have not been modified 
to harbour antibiotic resistance genes growing on agar plates containing Ampicillin during 
transformation (Davies and Davies, 2010; Choi, Ro and Yi, 2019). In specific reactions 
results being seen for the negative control can also relate to other issues. For example, in 
PCR it can also be used to check for multiple binding sites of the primers (Banasik et al., 
2016).  These issues can be extremely detrimental to the entire process therefore using 
controls can help to narrow down the problem, this should have been fully utilized at every 
step. 
Due to failure in the later stages of cloning the following should have been done, if time 
allowed.  Firstly, after restriction digest gel electrophoresis should have carried out with 
digested and undigested samples (Szeberényi 2013). The uncut plasmid will be supercoiled 




supercoiled (Stowell and Tweedie 2006). This can be done with the insert too. Once 
successful restriction digest is confirmed ligation can go ahead. Positive and negative 
controls at this stage are imperative as it can help rule out issues in with transformation. 
For example, linear plasmid with no ligase to control the presence of uncut vector, linear 
plasmid with ligase to control the presence of re-circularized vector; uncut plasmid to 
check the competency of cells and a ligation with buffer to check contamination (Carson et 
al., 2012; Carson et al., 2019). 
It is important to identify that too much time was focused on conducting transport assays 
on clones from other GusB projects, rather than on the success of my own. However, by 
including these clones in the scope on my work I was able to gain knowledge of how to 
conduct procedures I might have not reached with my own project. In addition to this, a 
previously undiscovered mutation in the pE429A clone was found after sequencing.  Once 
this was found, rather than conducting Gus assay using pNPG and iPTG, it would have 
been beneficial to test transport using X-Gluc tests. This was the method used in the 
original research project and would therefore allow better comparisons to be made to 
determine if the amino acid at position 218 was important for transport within the GusB 
protein. 
4.6 Recommendations for future work 
 
4.6.1 Recommendation for immediate progression of this study 
 
It would be logical to continue the cloning process for successfully fused DNA fragments 
obtained in this project. By repeating PCR amplification steps for successfully fused 
products, a higher volume of sample can be obtained to increase the chances of successful 
ligation. This in turn will increase the likelihood of transformation of desired DNA 
plasmids. Once transformants are produced and single colonies have been observed, 
extraction of plasmid DNA through mini-prep should follow. All samples should then be 
sequenced to determine whether the expected mutation was created within the sequence of 
gusB if this was successfully incorporated into the genome of the pTTQ18 plasmid.  
If nucleotide and protein sequences show that site directed mutagenesis was successful, 
transport activity should be assessed using transport tests in which iPTG is used to induce 
both the GusA and GusB on the plasmid, the pNPG substrate is then added. If the 
glucuronide transporter has been transcribed the substrate will be transported into the cell 




measured for bacteria concentration and OD405 for pNPG concentration. Positive and 
negative controls should be used as seen in section 2.24.2. 
Regarding the pE349A plasmid, transport activity tests using GUS assay should be 
repeated. This would provide further evidence that perhaps the mutation at position 349 
and 218 directly affects the transport mechanism of the GusB protein. It is important to 
remember that proteins within the MFS have a 12 TM helical structure comprising of two 
6 helix domains in which amino acids interact through charges and hydrogen bonding. 
Within the XylE protein specific amino acid residues within different domains have 
identified in molecular recognition functionality. Hydrogen bonds between the following 
residues were thought to form the binding site: (TM5), Gln288/Gln289/Asn294 (TM7), 
Trp392 (TM10) and Gln415 (TM11) making up eight hydrogen bonds, then Phe24 (TM1), 
Tyr298 (TM7) and Trp416 (TM11) form the sugar binding pocket. Mutations in these 
residues caused diminished function therefore a changed from a neutral amino acid to one 
with a positive charge could definitely effect these interactions (Wisedchaisri et al., 2014). 
Looking at the alignments for XylE and GusB there are some matches and amino acids 
with similar properties at these sites so it would be beneficial to investigate this further in 
addition to the pE349A/N218K mutant discovered in this project. 
As previously discovered by Stoebar (1961), the Glucuronide Transport Membrane protein 
has varying binding affinity for glucuronide substrates. When repeating transport activity 
tests, different glucuronides could also be used in addition to pNPG. The level of transport 
activity in addition to binding affinity for certain substrates could then be assessed using 
colorimetric analysis. Comparisons of the pE349A/D218 and pMJB33 proteins should then 
be made. The addition of a poly-histidine tag would allow purification of the mutated 
GusB protein (Hengen 1995; Mohanty and Wiener 2004). 
 
4.6.2 Future prospects should the molecular recognition site of GusB be 
located 
 
4.6.2.1 GusB as a potential Biosensor 
 
Professor Leland Clark Jr constructed the first biosensor in 1956. He studied how different 
analytes could be measured in the body using intelligent electrochemical sensors in the 
form of enzyme transducers to do so. This was demonstrated by an experiment where 
glucose oxidase was captured by an oxygen electrode with the use of a dialysis membrane 




purposes; the measurement of glucose levels within the blood could be used as indication 
of diabetes and allows for self-monitoring of the condition (Bartlett and Whitaker 1987; 
Yoo and Lee 2010; Fung Ang et al., 2015). From this point a range of different biosensors 
were constructed using this basic principle as a model. It was not until later that more 
advanced biosensors were introduced. By manipulating enzymes, nucleic acids, cell 
receptors, antibodies and intact cells different types of responses could be measured 
quantitatively using transducers such as electrochemical, optical, and thermometric (Turner 
and Malhotra 2003; Setford and Newman 2005). GusB transport assays including GUS 
substrates X-Gluc which produces a blue precipitate after hydrolysis by the GusA; and 
pNPG which produces a yellow colour when cleaved are efficient at providing fast visible 
chromogenic responses (Fedorenko 2011., Little et al., 2017) If the molecular recognition 
site could be manipulated to only transport specific molecules the GUS system could 
provide an instant visual response indicating the presence of the molecule in question 
It is possible that future GusB applications could involve making changes to the specificity 
of the binding site to recognise only specific substrates, discriminating certain glucuronides 
but transporting others creating a controlled and reliable identification system. However, 
first the position of the molecular recognition site needs to be located 
Identifying key amino acids within the molecular recognition can have numerous 
advantages. Should the molecular recognition site be located and if the amino acids that 
make up this structure are found, mutations could allow for sensitivity and specificity to be 
manipulated resulting in the recognition of particular glucuronide substrates (Chung Kim 
and Joon Kang 2008, Harris et al., 2017). If expressed together with GusA to cleave 
substrates and perhaps a fluorescent marker, this could be a useful tool in the detection of a 
whole range of chemical substances especially taking into consideration the variability of 
glucuronide molecules. 
By making these changes at nanoscale biosensors can be created. Biological biosensors are 
described as devices that identify the presence or concentration of an analyte, including 
biomolecules, biological structures and microorganisms (Mehrotra 2016).   
Using modified bacteria strains, which already encode the GusA glucuronidase protein 
plus GusB with a modified recognition site, a fluorescent marker or other visual marker 
would need to be expressed in conjunction with GusB to detect certain metabolites quickly 
and easily. One example could be the detection of analytes within urine. This could be 
useful to detect substances in drug testing, to detect changes in hormone levels relating to 




binding of transport of one substrate means that anything cleaved by GusA should be the 
metabolite of interest; this could then be measured via the colorimetric response.  
The applications for biosensors are great with medical uses; food, military and plant 
sciences making up just a few. One major use is for monitoring harmful substances present 
in the environment such as pesticides (Mehrotra 2016). Large scale use of pesticides for 
controlling unwanted organisms such as insects, weeds and bacteria is now a huge part of 
agriculture and although is beneficial to farmers in terms of productivity this can have 
detrimental effects on organisms and the surrounding area (Aktar et al., 2009; Verma and 
Bhardwaj 2015). The ability for these chemicals to spread through systems including the 
soil, area and water sources means that the poisonous nature of some pesticides will cause 
huge problems to organisms that ingest the substance and therefore a better system for 
detection is necessary (McEwen and Stephenson 1979; Aktar et al., 2009). 
The use of Gus system would mean detection would specific. In addition to this the process 
would be non-invasive, fast and the added advantage is it would not necessarily need to be 
conducted within a laboratory setting. 
 
4.6.2.2 GusB as a potential reporter gene 
 
The gusA gene of E. coli is currently used as an enzymatic reporter gene in various fields. 
Reporter genes allow the expression and the promoter activity to be assessed (Karimi et al., 
2009). One use of gusA is to test if bacteria are present in liquids by using chromogenic β-
glucuronides such as p-Nitro-Phenol-Glucuronide, if present this will be cleaved to 
produce pNP and glucuronic acid which produces a chromogenic response (Kim et al., 
2005; Palchette and Mascini, 2008). In addition to this gusA has been widely used within 
the plant industry in transgenic plants due to its absence in these organisms. This gene is 
inserted into plants and then tested using chromogenic studies such as X-Gluc (Jefferson et 
al., 1986; Tsomlexoglou et al., 2002). Tissues containing the gene will show a blue colour, 
which has helped with regards to promoter analysis of naturally occurring gene and with 
gene expression (Hull and Devic, 1995; Tehryung et al., 1999; Myronovskyi et al., 2011). 
Current GUS systems do however have limitations; a number of biochemical and 
molecular influences can affect expression of the GUS genes resulting in quantification of 
results being questioned due to inhibitors of Gus enzymes. It was found inhibitor 




coli enzyme (Fior and Gerola, 2009). This would surely be a downfall of this current 
system. 
Protein engineering of reporter genes is becoming increasingly common way to tackle 
inconclusive or unreliable results. One example being the Green Fluorescence Protein 
(GFP) from the jellyfish species Aequorea Victoria (Soboleski et al., 2005). A cloned 
version of this protein produces a visible fluorescent light when expressed without the need 
for other cofactors (Chalfie 1994). The discovery of GFP was pivotal in the molecular 
cloning and biological because of its easily detectable properties. It can be utilised as a 
reporter gene and screening tool to study gene expression, transfection and aids our 
understanding of many organisms and the systematics of biological systems (Chalfie 1994; 
Filmeier et al., 2000; Soboleski et al., 2005). Since the discovery of GFP in the 1960’s, it 
has been found that the protein generally overexpressed comparative to endogenous 
proteins, and the GFP may also cause disruptions in protein function (Michaelson and 
Phillips 2006). However, to combat such problems scientists have engineered the protein 
using mutagenesis techniques to alter a number of characteristics including the excitation 
and emission spectra, this allows for distinct markers to observe a number of biological 
events occurring at one time (Hanson and Köhler 2001; Kobayashi et al., 2008). As well as 
this structural and functional relationships can be visualised in vitro through illumination 
(Heim and Tsien 1996). 
If both gusA and gusB could be used together as a reporter system to test expression, in 
vivo studies may well be conducted. By including the glucuronide transporter as a 
secondary reporter under the same promoter as GusA, substrates could be transported and 
cleaved to produce a colorimetric response in the cells or tissue.  This would only occur if 
the gene of interest were expressed in the first place of course. This would mean that 
extracting cells and tissues for in vitro studies of expression might not be necessary.  
In addition to this site directed mutagenesis within GusB could mean specificity 
dramatically increased, other biological influences affecting the GUS system would be 
minimal and therefore current limitations might be reduced. Whether this is a valuable tool 
in the future depends on the continuation of study into the structure, function and 










Prior to undertaking this study, research regarding the molecular recognition site of GusB 
was scarce and therefore the decision to identify key amino acids relating to this was made. 
By creating mutations in the gusB gene amino acids would be changed in the final 
structure of the GusB protein. It was suspected that this would disrupt with the molecular 
recognition site causing changes in substrate affinity and binding. This would be achieved 
using molecular cloning techniques. 
Despite persisting efforts and troubleshooting of procedures, the process was unsuccessful. 
Fused DNA fragments, thought to encode a mutated gusB, were achieved through PCR 
amplification. When expressed these were hoped to produce mutations at position 27 and 
273. The cloning procedures that followed were conducted however; results could not be 
obtained and the desired products were not produced. In order to prove the mutations were 
successful, transformation and sequencing should be conducted. If these steps can confirm 
a site directed mutation has been achieved, transport tests via GUS assay can then detect 
whether substrate affinity and molecular recognition has been affected.  
This project however, did uncover new information regarded the mutated GusB protein 
pE349A. When sent for sequencing, the expected mutation was not just found at position 
349 but also a substitution from an uncharged Asparagine to a positively charged Lysine 
was incorporated into the sequence of gusB at position 218. GUS assay transport tests 
showed diminished transport compared to the pMJB33 protein with a functional GusB. It is 
advised that X-Gluc test are conducted to allow comparative results with previous 
research. In addition to this more sequence alignments to proteins within the MFS should 
be conducted to see if equivalent positions within these proteins have known links to the 
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 M  N  Q  Q  L  S  W  R  T  I  V  G  Y  S  L  G  D  V  A  N   
aacttcgccttcgcaatgggggcgctcttcctgttgagttactacaccgacgtcgctggc  
 N  F  A  F  A  M  G  A  L  F  L  L  S  Y  Y  T  D  V  A  G   
gtcggtgccgctgcggcgggcaccatgctgttactggtgcgggtattcgatgccttcgcc  
 V  G  A  A  A  A  G  T  M  L  L  L  V  R  V  F  D  A  F  A   
gacgtctttgccggacgagtggtggacagtgtgaatacccgctggggaaaattccgcccg  
 D  V  F  A  G  R  V  V  D  S  V  N  T  R  W  G  K  F  R  P   
tttttactcttcggtactgcgccgttaatgatcttcagcgtgctggtattctgggtgccg  
 F  L  L  F  G  T  A  P  L  M  I  F  S  V  L  V  F  W  V  P   
accgactggagccatggtagcaaagtggtgtatgcatatttgacctacatgggcctcggg  
 T  D  W  S  H  G  S  K  V  V  Y  A  Y  L  T  Y  M  G  L  G   
ctttgctacagcctggtgaatattccttatggttcacttgctaccgcgatgacccaacaa  
 L  C  Y  S  L  V  N  I  P  Y  G  S  L  A  T  A  M  T  Q  Q   
ccacaatcccgcgcccgtctgggcgcggctcgtgggattgccgcttcattgacctttgtc  
 P  Q  S  R  A  R  L  G  A  A  R  G  I  A  A  S  L  T  F  V   
tgcctggcatttctgataggaccgagcattaagaactccagcccggaagagatggtgtcg  
 C  L  A  F  L  I  G  P  S  I  K  N  S  S  P  E  E  M  V  S   
gtataccatttctggacaattgtgctggcgattgccggaatggtgctttacttcatctgc  
 V  Y  H  F  W  T  I  V  L  A  I  A  G  M  V  L  Y  F  I  C   
ttcaaatcgacgcgtgagaatgtggtacgtatcgttgcgcagccgtcattgaatatcagt  
 F  K  S  T  R  E  N  V  V  R  I  V  A  Q  P  S  L  N  I  S   
ctgcaaaccctgaaacggaatcgcccgctgtttatgttgtgcatcggtgcgctgtgtgtg  
 L  Q  T  L  K  R  N  R  P  L  F  M  L  C  I  G  A  L  C  V   
ctgatttcgacctttgcggtcagcgcctcgtcgttgttctacgtgcgctatgtgttaaat  
 L  I  S  T  F  A  V  S  A  S  S  L  F  Y  V  R  Y  V  L  N   
gataccgggctgttcactgtgctggtactggtgcaaaacctggttggtactgtggcatcg  
 D  T  G  L  F  T  V  L  V  L  V  Q  N  L  V  G  T  V  A  S   
gcaccgctggtgccggggatggtcgcgaggatcggtaaaaagaataccttcctgattggc  
 A  P  L  V  P  G  M  V  A  R  I  G  K  K  N  T  F  L  I  G   
gctttgctgggaacctgcggttatctgctgttcttctgggtttccgtctggtcactgccg  
 A  L  L  G  T  C  G  Y  L  L  F  F  W  V  S  V  W  S  L  P   
gtggcgttggttgcgttggccatcgcttcaattggtcagggcgttaccatgaccgtgatg  
 V  A  L  V  A  L  A  I  A  S  I  G  Q  G  V  T  M  T  V  M   
tgggcgctggaagctgataccgtagaatacggtgaatacctgaccggcgtgcgaattgaa  
 W  A  L  E  A  D  T  V  E  Y  G  E  Y  L  T  G  V  R  I  E   
gggctcacctattcactattctcatttacccgtaaatgcggtcaggcaatcggaggttca  
 G  L  T  Y  S  L  F  S  F  T  R  K  C  G  Q  A  I  G  G  S   
attcctgcctttattttggggttaagcggatatatcgccaatcaggtgcaaacgccggaa  
 I  P  A  F  I  L  G  L  S  G  Y  I  A  N  Q  V  Q  T  P  E   
gttattatgggcatccgcacatcaattgccttagtaccttgcggatttatgctactggca  
 V  I  M  G  I  R  T  S  I  A  L  V  P  C  G  F  M  L  L  A   
ttcgttattatctggttttatccgctcacggataaaaaattcaaagaaatcgtggttgaa  
 F  V  I  I  W  F  Y  P  L  T  D  K  K  F  K  E  I  V  V  E   
attgataatcgtaaaaaagtgcagcagcaattaatcagcgatatcactaattaa  

















































































5’- GTAGCAAAGCCCACAGCCCAT -3’  
  
ER1gusBF (based on pMJB33 clone)  
5’-aataagaattcatgaatcaacaactctcctg-3’  
  






















3. Examples of procedures carried out in the lab: Please note this is a sample, not 
all pages are included.  
Making of LB media and plates  























































































  Restriction Digest 
 















Shrimp Alkaline Phosphatase (SAP) Treatment 





























































































































































































































































































7. Evaluative Supplement 
 
First and foremost, the most rewarding part of undertaking this 
investigation was the process of taking a subject which was new to me and 
being able to develop a vast understanding of all aspects concerned with 
the topic. When I first started this project, my knowledge surrounding the 
gusB gene and the GUS operon was minimal. I understood the basics of 
the system due to past biomolecular studies however, the depth of 
understanding needed for this was extensive and a lot of reading, questions 
and hard work was put in to achieve the results in the project and to obtain 
the knowledge surrounding the subject area. This was ongoing and at every 
single point for desk-based research was needed to understand the practical 
side of the project. This however was not the most difficult part for me, it 
was in fact the lab work which proved to be the most challenging.   
When the project began molecular cloning techniques and mutagenesis 
were not skills that I possessed and although I was familiar with the theory 
I had not previously conducted and designed my own experiments. Behind 
each lab procedure carried out is a basic protocol which needed to be 
shaped and moulded to fit with what I was trying to achieve, although in 
theory what I was trying to do was easy in practice getting experiments 
exactly right and getting any sort of result was much harder than 
anticipated. Often the lab work became a trial and error, educated guesses 
as to why certain experiments would not work were constructed based on 
reading troubleshoot guides, journals, books and articles and discussions 
with my supervisor and fellow students. Each step in the cloning process 
threw up new challenges which sometimes created knock backs and made 
me feel dis-heartened because the work being put in was not giving back 
the results I needed.   
It came to my attention that in fact conducting science experiments of this 
kind was sensitive and the smallest issue could bring adverse effects the 
results I obtained. The inability for me to complete the cloning process on 
the last step of this project brought me great distain and a sense of under 
achieving as this was my ultimate goal with the project and my samples 
could not be checked to see if they were in fact clones or related to the 
molecular recognition site of GusB. I did not achieve the initial goal set out 
however the wealth of knowledge I gained both in lab and in regard to the 
subject matter is not comparable to the knowledge I had at the beginning.   
Another setback was ill health during the project which at times meant lab 
work could not be completed, along with this hold ups due to chemical 
order processing and machine and equipment repairs created false results 
and also a dis-jointed journey throughout the cloning process. Some of the 
issues also can attributed to my own personal struggles, I often try and 
work alone trying to Figure things out for myself. This lead to repeated 
experiments and lot of unsuccessful attempts, if discussed properly with 
my supervisor and other students at the time this may have reduced the 
number of mistakes made. Although weekly plans were put in place better 
time management could have ensured that enough time was given for each 
step taking into consideration any additional work that may need to be 




the project rather than unrealistic expectation which came from a lack of 
experience in the lab.     
Besides the difficulties faced in this project I felt passionate about the 
subject and the more I learnt the more I respected the work being done in 
the field of molecular biology. The practice is difficult, uncertain and at 
times tedious however it is through this practice that we can uncover the 
basic building blocks and processes responsible for driving life itself. The 
desire to understand the intricacies of this subject seemed natural for me 
especially when it related to me and everyone around me. Frustration from 
being unable to obtain results drives me even more to carry on learning and 
trying to uncover more information about gusB, I have invested a lot of 
time into the gene which sparks intrigue and questions about this gene still 
which are still left unanswered.    
Apart from all of the technical skills I obtained, my supervisor also 
suggested I try to hone my writing skills however, after years of bad habits 
and being taught incorrectly this was hard for me. By comparing articles, 
learning to engage the reader, creating a story and setting themes in my 
writing I was able to improve my work. This is not just necessary for 
writing a thesis but will also be transferable in other areas of my life.   
Doing this Master of Research project has made me realise that science is 
what I want to pursue in life, it has the ability to drive you to distraction 
but when results are achieved the feeling of accomplishment completely 
outweighs the negatives. Science, especially molecular biology is on the 
forefront of technology. Having finished this project, I have now started a 
job within Pharmacological research on Phase I drugs. I hope to use all I 

















































































9. GusB and XylE pair alignment using the Lalign software on NCBI. 
 
n-w opt: -25  Z-score: 83.6  bits: 24.8 E(1): 0.00039 
global/global (N-W) score: -25; 19.3% identity (48.4% similar) in 517 aa 
overlap (1-491:1-457) 
 
               10        20        30        40        50        60 
XylE   MNTQYNSSYIFSITLVATLGGLLFGYDTAVISGTVESLNTVFVAPQNLSESAANSLLGFC 
       :: : .   : . .:  . ... :.. .         : . ..   ... .::...: .  
GusB   MNQQLSWRTIVGYSLGDVANNFAFAMGALF-------LLSYYTDVAGVGAAAAGTMLLLV 
               10        20        30               40        50    
 
               70        80         90       100       110          
XylE   VASALIGCIIGGALGGYCSNRFGR-RDSLKIAAVLFFISGVGSAWPELGFTSINPDNTVP 
        .   .. ...: .    ..:.:. :  : .... ..: .:   :    ..  . ...:  
GusB   RVFDAFADVFAGRVVDSVNTRWGKFRPFLLFGTAPLMIFSVLVFWVPTDWS--HGSKVVY 
            60        70        80        90       100         110  
 
     120       130       140         150       160       170        
XylE   VYLAGYVPEFVIYRIIGGIGVGLASMLS--PMYIAELAPAHIRGKLVSFNQFAIIFGQLL 
       .::. :.   . : ...    .::. ..  :.  :.:. :  ::          : ..:  
GusB   AYLT-YMGLGLCYSLVNIPYGSLATAMTQQPQSRARLGAA--RG----------IAASLT 
              120       130       140       150                     
 
       180       190       200       210       220       230        
XylE   VYCVNYFIARSGDASWLNTDGWRYMFASECIPALLFLMLLYTVPESPRWLMSRGKQEQAE 
         :. ..:. :   :  .     : : .  . :.  ..: .   .: :           : 
GusB   FVCLAFLIGPSIKNSSPEEMVSVYHFWT-IVLAIAGMVLYFICFKSTR-----------E 
      160       170       180        190       200                  
 
       240       250       260       270       280       290        
XylE   GILRKIMGNTLATQAVQEIKHSLDHGRKTGGRLLMFGVGVIVIGVMLSIFQQFVGINVVL 
       ...: .   .:   ..: .:..          :.:. .:.. .     ... :.     : 
GusB   NVVRIVAQPSLNI-SLQTLKRNRP--------LFMLCIGALCV-----LISTFAVSASSL 
        210        220               230       240            250   
 
       300       310       320       330       340       350        
XylE   YYAPEVFKTLGASTDIALLQTIIVGVINLTFTVLAIMTVDKFGRKPLQIIGALGMAIGMF 
       .:.  :..  :  : ..:.:.. ::..  .  : ..  : ..:.:   .::::  . :.. 
GusB   FYVRYVLNDTGLFTVLVLVQNL-VGTVASAPLVPGM--VARIGKKNTFLIGALLGTCGYL 
            260       270        280         290       300          
 
       360       370       380       390       400       410        
XylE   SLGTAFYTQAPGIVALLSMLFYVAAFAMSWGPVCWVLLSEIFPNAIRGKALAIAVAAQWL 
        .  .   . :  .. :..     . .:.   : :.: ..       :. :. .:  . : 
GusB   LFFWVSVWSLPVALVALAIASIGQGVTMT---VMWALEADTVE---YGEYLT-GVRIEGL 
     310       320       330          340          350        360   
 
       420       430       440              450                     
XylE   ANYFVSWTFPMMDKNSWLVAHFHNGFSYWIYG-------CMGV-------------LAAL 
       .  . :.:    .  .  .  :  :.: .: .        ::.             :: . 
GusB   TYSLFSFTRKCGQAIGGSIPAFILGLSGYIANQVQTPEVIMGIRTSIALVPCGFMLLAFV 
            370       380       390       400       410       420   
 
       460       470       480          490  
XylE   FMWKFVPETKGKTLEELEALWEPETKKTQQTA---TL 
       ..: : : :  : ..:. .  . . :  ::     :  
GusB   IIW-FYPLTD-KKFKEIVVEIDNRKKVQQQLISDITN 





10. GusB and SV2A pair alignment using the Global Lalign software on NCBI 











11. GusB and MelB pair alignment using the Global Lalign software on NCBI 




















12. A 3D representation of the predicted structure of the GusB protein: This 
includes the alpha helices and beta strand which interact to the tertiary stricture as 
seen below. Below is a key showing which amino acids can be found in each 
helices the colour on the key relates to the colour of the helices seen. The site of 
mutations made in this project has been highlighted on the sequence using red 
boxes. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
